Data / Research funding / Congenital Heart Disease
Congenital Heart Disease: 583 NIH awards ($676.3M) to 149 organizations
583 NIH awards ($676.3M) in the NIH spending category Congenital Heart Disease, to 149 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 583 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Ola HAWAII | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $25,522,287 | September 23, 1997 | May 31, 2027 | HEDGES, JERRIS ROBERT | reporter.nih.gov |
| Administrative Coordinating Center: Bench to Bassinet Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $21,378,391 | January 1, 2016 | December 31, 2025 | OLLBERDING, NICHOLAS J | reporter.nih.gov |
| Cavopulmonary Assist to Reverse the Fontan | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,543,627 | September 14, 2020 | August 31, 2025 | RODEFELD, MARK D | reporter.nih.gov |
| PET/MRI imaging of mitral valve prolapse | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $6,137,934 | August 25, 2023 | June 30, 2028 | TRIVIERI, MARIA GIOVANNA | reporter.nih.gov |
| Cardiovascular Development Data Resource Center (CDDRC) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,768,733 | August 20, 2020 | July 31, 2025 | YOST, H. JOSEPH | reporter.nih.gov |
| Decrypting Variants of Uncertain Significance in Long-QT Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $5,148,685 | August 1, 2014 | July 31, 2026 | GEORGE, ALFRED L. | reporter.nih.gov |
| Toward efficient performance for deep learning on medical imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,624,228 | April 1, 2020 | March 31, 2030 | ARNAOUT, RIMA | reporter.nih.gov |
| Evaluating Assessment and Medication Treatment of ADHD in Children with Down Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $4,182,561 | May 1, 2024 | August 31, 2025 | ESBENSEN, ANNA J. | reporter.nih.gov |
| Probing Phenotype-Genotype Relations After Whole Genome Sequencing in Patients with Atrial Fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,058,145 | September 1, 2021 | July 31, 2026 | SHOEMAKER, MOORE BENJAMIN | reporter.nih.gov |
| Pulmonary Valved Graft with Regeneration Potential for Pediatric Patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,958,584 | May 24, 2019 | February 28, 2027 | HOUDE, AJAY | reporter.nih.gov |
| Exploring the relationship between advanced multimodal brain MRI phenotypes, genes and cognitive outcome in adults with CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,938,586 | March 15, 2021 | February 28, 2027 | GRANT, PATRICIA ELLEN | reporter.nih.gov |
| Targeting Mitochondria in Single Ventricle Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,873,722 | March 15, 2021 | January 31, 2026 | MIYAMOTO, SHELLEY DEANNE | reporter.nih.gov |
| Prospective sudden cardiac death risk stratification using CMR and echocardiography machine learning in mitral valve prolapse | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,864,384 | May 26, 2020 | April 30, 2026 | DELLING, FRANCESCA N | reporter.nih.gov |
| Optical Tools to Assess the Role of Cardiac Function in the Development of Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,824,765 | July 1, 2015 | February 28, 2027 | JENKINS, MICHAEL W. | reporter.nih.gov |
| Cilia in Heart Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,728,670 | February 15, 2019 | January 31, 2026 | BRUECKNER, MARTINA | reporter.nih.gov |
| Cardiogenesis: Molecular Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,717,603 | January 10, 1997 | May 31, 2028 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Mechanism of Myocardial Fibrosis Induced by Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,657,264 | September 5, 2024 | July 31, 2028 | LEVINE, ROBERT A | reporter.nih.gov |
| Improving Tissue Engineered Vascular Graft Performance via Computational Modeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,638,571 | January 1, 2018 | March 31, 2027 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| 1/2 Allogeneic Human Mesenchymal Stem Cell (MSC) Injection in Patients with Hypoplastic Left Heart Syndrome: A Phase IIb Clinical Trial | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,521,212 | September 15, 2020 | August 31, 2025 | BERGER, STUART | reporter.nih.gov |
| Genetic Control of Cardiac Development: Congenital Heart Disease Gene Discovery in Drosophila | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,338,929 | August 1, 1995 | June 30, 2025 | BODMER, ROLF | reporter.nih.gov |
| Development of a Polymeric Percutaneous Pulmonary Valve for Use in Young Children | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,231,750 | August 15, 2016 | February 28, 2029 | HARRINGTON, DANIEL A | reporter.nih.gov |
| Exercise Intolerance in Non Obstructive Hypertrophic Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,213,836 | May 1, 2022 | February 28, 2027 | ABRAHAM, THEODORE P | reporter.nih.gov |
| Microstructural Response of the Myocardium to Mechanical Load | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,205,295 | July 1, 2021 | May 31, 2026 | SOSNOVIK, DAVID E | reporter.nih.gov |
| DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,158,101 | August 6, 2021 | December 31, 2027 | TANG, BEVERLY | reporter.nih.gov |
| Genetic modifiers of congenital heart disease in 22q11.2 deletion syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,070,980 | February 1, 2022 | January 31, 2027 | MORROW, BERNICE E | reporter.nih.gov |
| Genetic determinants of 4D genome folding in human cardiac development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,069,960 | September 21, 2020 | August 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Mechanobiology of Cardiac Outflow Tract Morphogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,068,575 | March 15, 2022 | February 28, 2027 | BUTCHER, JONATHAN TALBOT | reporter.nih.gov |
| Metabolic profiling and comprehensive metabolic pathway mapping: a systems biology approach to cardiovascular failure and organ injury following infant congenital heart disease surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,061,754 | May 1, 2021 | April 30, 2027 | DAVIDSON, JESSE | reporter.nih.gov |
| Gene-by-environment interactions that affect exposure-mediated congenital heart disease | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $3,058,037 | September 10, 2021 | June 30, 2027 | WHITEHEAD, JOHN ANDREW | reporter.nih.gov |
| Early cardiac progenitors | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,025,531 | July 1, 2013 | July 31, 2029 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| Heightened hypoxia and DNA methylation in heart defects of diabetic embryopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,020,733 | September 15, 2022 | July 31, 2027 | YANG, PEIXIN | reporter.nih.gov |
| Cell-Type Specific Mechanisms of Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,008,247 | September 1, 2025 | August 31, 2029 | CHI, NEIL C | reporter.nih.gov |
| In vivo Characterization of Regulatory Variant Pathogenicity in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,998,900 | January 1, 2022 | December 31, 2026 | VISEL, AXEL | reporter.nih.gov |
| Development of an oxygen delivery biotherapeutic for the preservation of myocardial function during pediatric cardiopulmonary bypass | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $2,986,551 | August 1, 2017 | August 31, 2027 | WINGER, JONATHAN A | reporter.nih.gov |
| Sudden Death Risk Assessment and Mechanistic Insights in Arrhythmic Mitral Valve Prolapse Using Cardiac MRI and Circulating Proteomic Biomarkers | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,960,139 | September 5, 2024 | June 30, 2029 | SHAH, DIPAN J. | reporter.nih.gov |
| Polyunsaturated fatty acids as anti-arrhythmic agents. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,942,029 | September 15, 2016 | March 31, 2026 | BARRO-SORIA, RENE | reporter.nih.gov |
| Neurometabolic Outcomes of Different Cardiopulmonary Bypass Strategies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,911,403 | February 15, 2021 | January 31, 2026 | HANLEY, FRANK | reporter.nih.gov |
| Pharmacologic Contributors to Patent Ductus Arteriosus | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,898,557 | July 1, 2022 | June 30, 2027 | REESE, JOHN JEFFREY | reporter.nih.gov |
| Role of Cyclohexanone Toxicity in Mediating Congenital Cardiac Surgery Outcomes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,885,985 | June 1, 2022 | May 31, 2027 | JANTZIE, LAUREN LEIGH COONEY | reporter.nih.gov |
| Pathophysiologic Mechanism for Arrhythmias and Impaired Aerobic Capacity in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,871,936 | August 1, 2021 | July 31, 2027 | EGBE, ALEXANDER | reporter.nih.gov |
| A protein traffic control system that regulates left-right patterning and heart development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,868,559 | September 1, 2021 | August 31, 2025 | ROHATGI, RAJAT | reporter.nih.gov |
| Computer Modeling of the Tricuspid Valve in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,867,475 | July 20, 2020 | June 30, 2026 | JOLLEY, MATTHEW | reporter.nih.gov |
| Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,861,908 | April 1, 2021 | March 31, 2026 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Cilia and Valvular Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,857,857 | July 1, 2016 | March 31, 2027 | NORRIS, RUSSELL | reporter.nih.gov |
| Altered Lymphatic Function and Development in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,838,877 | June 1, 2016 | May 31, 2027 | DATAR, SANJEEV A. | reporter.nih.gov |
| Epigenetic regulation in cardiac development | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,819,542 | April 1, 2023 | March 31, 2030 | HUANG, YUN | reporter.nih.gov |
| 4D Multimodal Image-Based Modeling for Bicuspid Aortic Valve Repair Surgery | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,803,281 | June 1, 2022 | May 31, 2027 | POUCH, ALISON MARIE | reporter.nih.gov |
| Modern Analytics to Improve Quality & Outcome Assessments Following Congenital Heart Surgery | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,799,826 | June 15, 2022 | May 31, 2027 | NORMAND, SHARON-LISE TERESA | reporter.nih.gov |
| RE-ENERGIZE FONTAN - RandomizEd Exercise INtERvention desiGned to MaximIZE Fitness in Pediatric FONTAN patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,798,890 | March 10, 2020 | February 28, 2026 | SELAMET TIERNEY, ELIF SEDA | reporter.nih.gov |
| Comparing Direct and Indirect Methods for Cascade Screening in Familial Hypercholesterolemia (FH) and Long QT Syndrome (LQTS) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,785,718 | June 1, 2022 | May 31, 2027 | BEITELSHEES, AMBER L | reporter.nih.gov |
| An expandable polymeric valved conduit to repair congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,774,182 | December 15, 2020 | November 30, 2026 | FERRARI, GIOVANNI | reporter.nih.gov |
| Expanding on a new paradigm for MRI in pediatric congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,744,758 | July 15, 2015 | March 31, 2026 | FINN, JOHN PAUL | reporter.nih.gov |
| Integrative Approach to Divergent Remodeling in Thin Filament Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,735,889 | December 1, 2003 | November 30, 2026 | TARDIFF, JIL C | reporter.nih.gov |
| Mechanisms of DMP Development and Atrioventricular Septation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,723,098 | September 1, 2014 | August 31, 2027 | WESSELS, ARNO | reporter.nih.gov |
| Experimental and Computational Studies in Genetic Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,674,553 | May 1, 2022 | April 30, 2027 | MOUSSAVI-HARAMI, FARID | reporter.nih.gov |
| Brain Injury and Dysmaturation in Newborns with Congenital Heart Disease Born Preterm | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,638,985 | March 1, 2023 | February 28, 2028 | MCQUILLEN, PATRICK SEAN | reporter.nih.gov |
| Off-label drugs in cardiology: evaluating age- and disease-appropriate therapies | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2025 | $2,627,273 | March 1, 2022 | February 28, 2027 | POSNACK, NIKKI GILLUM | reporter.nih.gov |
| Cell fate choices by Tbx1 in forming the mammalian heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,603,457 | August 20, 2020 | April 30, 2029 | MORROW, BERNICE E | reporter.nih.gov |
| Pediatric Heart Disease: Getting from Mutations to Therapeutics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,582,324 | February 15, 2017 | January 31, 2025 | GELB, BRUCE D | reporter.nih.gov |
| Establishing Efficacy for the Congenital Heart Disease Physical Activity Lifestyle Intervention | NIH | National Institute of Nursing Research | 2022 to 2025 | $2,554,158 | September 23, 2022 | June 30, 2027 | JACKSON, JAMIE L. | reporter.nih.gov |
| Tissue chips for precision treatment of catecholaminergic polymorphic ventricular tachycardia | NIH | National Center for Advancing Translational Sciences | 2022 to 2024 | $2,546,193 | September 1, 2020 | July 31, 2025 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Phase IIB Transmural Systems Transcatheter Cavopulmonary Bypass Endograft | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,544,747 | June 15, 2021 | November 30, 2024 | RAFIEE, NASSER | reporter.nih.gov |
| Mechanisms of Clinical and Hemodynamic Response to Pulmonary Vasodilator Therapy in Fontan physiology | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,530,672 | December 20, 2021 | November 30, 2026 | EGBE, ALEXANDER | reporter.nih.gov |
| Fine-scale Spatiotemporal Mapping of Cellular Regulatory Networks Directing Heart Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,499,248 | August 1, 2020 | July 31, 2025 | CHI, NEIL C | reporter.nih.gov |
| Beyond Gene Dosage: Understanding Down Syndrome via 4D Genome Organization | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,496,816 | September 18, 2020 | August 31, 2025 | LI, WENBO | reporter.nih.gov |
| Molecular pathogenesis of congenital heart disease mediated by neural crest and second heart field cells | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,484,708 | May 12, 2022 | April 30, 2027 | MORROW, BERNICE E | reporter.nih.gov |
| NEDD4 in right ventricular development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,473,604 | September 1, 2021 | August 31, 2026 | FANG, XI | reporter.nih.gov |
| A system approach to the analysis of Heterotaxy Candidate Genes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $2,462,797 | April 23, 2020 | January 31, 2025 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,460,707 | February 15, 2021 | January 31, 2027 | ZHAO, MINGTAO | reporter.nih.gov |
| Obscurin-kinase 1/N-cadherin: a new signaling axis in cardiac structure/function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,460,554 | August 5, 2022 | May 31, 2027 | KONTROGIANNI-KONSTANTOPOULOS, AIKATERINI | reporter.nih.gov |
| White Matter Protection in the Fetus with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,459,987 | April 1, 2020 | February 28, 2026 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| A Gata456 Pipeline of Discovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,432,169 | January 10, 2017 | December 31, 2023 | EVANS, TODD R | reporter.nih.gov |
| Gene regulatory networks for heart development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,410,652 | January 1, 2021 | December 31, 2025 | BRUNEAU, BENOIT GAETAN | reporter.nih.gov |
| A Novel computational approach to optimize Fontan and improve surgical predictability | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,410,109 | February 1, 2022 | January 31, 2027 | GOVINDARAJAN, VIJAY | reporter.nih.gov |
| 2/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) - DCC Resubmission | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,393,677 | July 1, 2024 | June 30, 2029 | DAS, ABHIK | reporter.nih.gov |
| Small molecule therapeutic for calcific aortic valve disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,378,349 | August 1, 2023 | May 31, 2027 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,366,065 | September 1, 2022 | August 31, 2026 | KHEIR, JOHN NAGI | reporter.nih.gov |
| Generation of four-chambered hearts through organoid fusions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,358,480 | September 1, 2024 | August 31, 2026 | LI, GUANG | reporter.nih.gov |
| Development of a Mirror-Image Natural Product as an Antiarrhythmic Therapeutic | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,330,311 | March 17, 2020 | February 28, 2025 | JOHNSTON, JEFFREY NICHOLAS | reporter.nih.gov |
| Rescue of Autoimmune-Associated Long QT Syndrome by Decoy Peptides | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,309,947 | August 19, 2022 | July 31, 2027 | BOUTJDIR, MOHAMED | reporter.nih.gov |
| Cell Therapy for Neuroprotection in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,294,475 | December 15, 2017 | April 30, 2027 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| Genetic and Hemodynamic Effects on Prenatal Cortical Development in Congenital Heart Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $2,289,171 | July 1, 2020 | March 31, 2026 | IM, KIHO | reporter.nih.gov |
| Function and regulation of chromatin remodeling complexes in cardiac development and disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,274,375 | September 15, 2022 | July 31, 2026 | CONLON, FRANK LEO | reporter.nih.gov |
| Oxylipin Signaling in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,228,649 | January 1, 2021 | November 30, 2026 | AGUIRRE, AITOR | reporter.nih.gov |
| Functional Genomics of Cardiac Sodium Channel Variants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,197,662 | January 1, 2020 | November 30, 2024 | RODEN, DAN M | reporter.nih.gov |
| Optogenetic regulation of intra-ciliary calcium signaling in cardiac situs development | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,193,015 | July 1, 2022 | June 30, 2027 | YUAN, SHIAULOU | reporter.nih.gov |
| Acute Imposition of Fontan Physiology in The Single Ventricle Patient: Effects on Fibrosis, Function and Drug Intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,190,858 | July 1, 2020 | June 30, 2026 | FOGEL, MARK A | reporter.nih.gov |
| The Risk of Acquired Neonatal Significant brain Injury during perinatal Transition in Congenital Heart Disease: TRANSIT CHD study | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,188,348 | May 1, 2022 | February 28, 2027 | PEYVANDI, SHABNAM | reporter.nih.gov |
| The role of RNA binding proteins in heart development and congenital heart defects | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,181,968 | April 12, 2023 | April 30, 2027 | KUYUMCU-MARTINEZ, MUGE NESLIHAN | reporter.nih.gov |
| Novel function of a mitochondria phosphatase in cardiac development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,163,950 | July 1, 2021 | June 30, 2025 | CHEN, JU | reporter.nih.gov |
| Mechanistic clinical trial of β-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,148,915 | July 1, 2021 | January 31, 2024 | KUHN, BERNHARD | reporter.nih.gov |
| Mechanism and Function of Cardiac Transcriptional Repression Networks | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,136,223 | July 16, 2021 | June 30, 2025 | CONLON, FRANK LEO | reporter.nih.gov |
| Development of a Fully-Implantable Ventricular Assist Device for Neonates and Children with Heart Failure - with Magnetic Levitation to Improve Hemocompatibility | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,115,146 | August 1, 2020 | June 30, 2025 | FRAZIER, O. H. | reporter.nih.gov |
| Mechanisms underlying myxomatous valve disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,112,156 | August 1, 2021 | May 31, 2026 | WAXMAN, JOSHUA | reporter.nih.gov |
| The mechanisms and roles of mitochondria dysfunction in cardiac arrhythmogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,098,803 | August 1, 2023 | May 31, 2027 | TERENTYEV, DMITRY A | reporter.nih.gov |
| ROS Mechanisms in BAV Aortopathy | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,094,708 | July 1, 2021 | June 30, 2026 | GLEASON, THOMAS GILLETTE | reporter.nih.gov |
| Uncertainty aware virtual treatment planning for peripheral pulmonary artery stenosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,093,561 | July 1, 2023 | June 30, 2028 | MARSDEN, ALISON L | reporter.nih.gov |
| 2/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,091,921 | April 1, 2023 | March 31, 2030 | RICE, MADELINE MURGUIA | reporter.nih.gov |
| DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,088,353 | February 15, 2022 | March 31, 2026 | TANG, BEVERLY | reporter.nih.gov |
| Proteoglycan Metabolism During Cardiac Valve Development and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,080,075 | January 1, 2022 | December 31, 2026 | KERN, CHRISTINE BRUINS | reporter.nih.gov |
| Linking State Medicaid and Congenital Heart Surgical Registry Data: Building Capacity to Assess Disparities in Longitudinal Outcomes and Value for Children with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,070,625 | January 5, 2020 | June 30, 2030 | ANDERSON, BRETT ROMEO | reporter.nih.gov |
| 5 D impulse mapping in the embryonic heart | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,066,665 | January 1, 2023 | December 31, 2026 | ROLLINS, ANDREW MARTIN | reporter.nih.gov |
| A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,061,658 | September 11, 2019 | February 28, 2026 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| The Role of PRDM16 in Cardiac Development and Cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,054,619 | July 15, 2020 | May 31, 2025 | BOUDINA, SIHEM | reporter.nih.gov |
| Signaling by beta 1 integrins regulates ventricular wall morphogenesis and compaction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,037,504 | November 15, 2014 | May 31, 2026 | WU, MINGFU | reporter.nih.gov |
| Wnt Signaling in Cardiac Conduction and Arrhythmogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,037,430 | January 1, 2016 | February 28, 2026 | RENTSCHLER, STACEY LYNN | reporter.nih.gov |
| Aortic Valve Disease: Mechanisms and Therapeutic Approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,037,372 | February 10, 2020 | January 31, 2025 | SRIVASTAVA, DEEPAK | reporter.nih.gov |
| Functional implications of CPVT1-associated RyR2 mutations in human cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,028,489 | September 1, 2021 | July 31, 2026 | MORAD, MARTIN | reporter.nih.gov |
| Determining the genetic and social determinants of heart failure and mortality in patients with congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,019,406 | July 1, 2023 | January 31, 2026 | LANDSTROM, ANDREW P. | reporter.nih.gov |
| Multimodal AI for Precise Clinical and Genetic Diagnosis of Congenital Heart Disease | NIH | Office of the Director, National Institutes of Health | 2025 | $2,013,196 | September 8, 2025 | September 7, 2026 | MILOSAVLJEVIC, ALEKSANDAR | reporter.nih.gov |
| Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,012,689 | August 25, 2023 | July 31, 2028 | EGBE, ALEXANDER | reporter.nih.gov |
| Change of Institution | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,991,250 | January 1, 2017 | June 30, 2024 | BURNS, CAROLINE E | reporter.nih.gov |
| Lipid Peroxidation-Induced Mitochondrial Injury Inhibits Vascular Function in Single Ventricle Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,984,499 | July 1, 2023 | May 31, 2027 | REDDY, SUSHMA | reporter.nih.gov |
| 1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,979,315 | March 21, 2022 | February 28, 2027 | BACKES, CARL | reporter.nih.gov |
| Integrating Volumetric Light-Field with Computational Fluid Dynamics to Study Myocardial Trabeculation and Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,975,848 | August 1, 2021 | May 31, 2026 | HSIAI, TZUNG K | reporter.nih.gov |
| Novel Therapeutics for Timothy Syndrome and Related Cardiac Channelopathy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,964,096 | September 1, 2023 | May 31, 2027 | YAZAWA, MASAYUKI | reporter.nih.gov |
| Epigenetic-mediated Notch pathway activation promotes elastin aortopathy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,957,640 | February 1, 2023 | January 31, 2028 | GREIF, DANIEL | reporter.nih.gov |
| Rational Design from Cryo-EM Structures of High-Affinity Ryanodine Receptor Ligands Based on Natural Peptides | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,951,142 | July 10, 2023 | June 30, 2027 | VALDIVIA, HECTOR H | reporter.nih.gov |
| Genomic Effects on Right Ventricular Function, Clinical Features and Outcomes in CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,948,211 | September 30, 2009 | July 31, 2025 | NEWBURGER, JANE W. | reporter.nih.gov |
| A Versatile Chemical-Genetic Approach to Determine Bases for Arrhythmogenesis and Sodium Channelopathies | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,946,518 | December 22, 2022 | November 30, 2026 | AHERN, CHRISTOPHER A | reporter.nih.gov |
| Endothelial subpopulations in heart valve development and congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,915,051 | December 15, 2020 | November 30, 2025 | YUTZEY, KATHERINE E | reporter.nih.gov |
| Human iPSC-derived atrial cardiomyocytes to model atrial fibrillation in a dish | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,914,578 | January 17, 2020 | December 31, 2024 | DARBAR, DAWOOD | reporter.nih.gov |
| Accelerating research to advance care for adults with congenital heart disease through development of validated scalable computational phenotypes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,910,551 | July 10, 2020 | May 31, 2025 | OPOTOWSKY, ALEXANDER R. | reporter.nih.gov |
| Engineered BacNav and BacCav for Improved Excitability and Contraction | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $1,900,343 | May 1, 2022 | January 31, 2027 | BURSAC, NENAD | reporter.nih.gov |
| Coronary artery dysfunction in OSA: Role of mineralocorticoid receptors | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,880,847 | June 1, 2023 | May 31, 2028 | BADRAN, MOHAMMAD | reporter.nih.gov |
| Mechanisms governing the differentiation and maintenance of atrial identity | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,871,877 | April 1, 2023 | March 31, 2027 | WAXMAN, JOSHUA | reporter.nih.gov |
| The Cardiac Atlas Project | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,871,310 | January 1, 2014 | June 30, 2025 | MCCULLOCH, ANDREW D. | reporter.nih.gov |
| Long-term Outcomes after Interventions for Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,858,355 | April 1, 2014 | July 31, 2025 | KOCHILAS, LAZAROS K. | reporter.nih.gov |
| Hyperglycemia of Maternal Diabetes Induces Cardiac Isl1 Positive Progenitor Dysfunction Leading to Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,845,222 | August 28, 2020 | June 30, 2025 | YANG, PEIXIN | reporter.nih.gov |
| Early Prediction of Spontaneous Patent Ductus Arteriosus (PDA) Closure and PDA-Associated Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,843,596 | December 15, 2018 | November 30, 2025 | SLAUGHTER, JONATHAN LEE | reporter.nih.gov |
| Partial and Controlled Depletion of SR Calcium by RyR Agonists Prevents Calcium-dependent Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,838,106 | January 1, 2023 | December 31, 2026 | VALDIVIA, HECTOR H | reporter.nih.gov |
| Post-transcriptional regulation of Kv11.1 (hERG) channel expression by alternative splicing and polyadenylation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,834,304 | June 1, 2022 | May 31, 2027 | ZHOU, ZHENGFENG | reporter.nih.gov |
| Digoxin Pharmacodynamics in Infants with Heart Failure due to Single Ventricle Congenital Heart Disease | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,830,595 | April 1, 2022 | February 28, 2027 | HORNIK, CHRISTOPH | reporter.nih.gov |
| Identifying and applying genetic variation relevant to clinical outcomes for individuals with congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,810,339 | August 1, 2020 | July 31, 2025 | SHEN, YUFENG | reporter.nih.gov |
| Cellular Stress-Induced Gene Dysregulation in Heart Defects Formation of Diabetic Pregnancy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,809,936 | July 1, 2020 | June 30, 2025 | YANG, PEIXIN | reporter.nih.gov |
| Fetal Brain MRI as a Predictor of Late Neurodevelopmental Outcome in Congenital Heart Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $1,800,997 | January 1, 2022 | December 31, 2026 | ROLLINS, CAITLIN | reporter.nih.gov |
| Understanding Cardiac C-Looping Using Microscale In Vitro Models | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,800,914 | July 7, 2021 | May 31, 2026 | WAN, LEO Q. | reporter.nih.gov |
| Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $1,795,134 | July 1, 2010 | June 30, 2027 | NING, MINGMING | reporter.nih.gov |
| Gene x Environment Interactions and Congenital Heart Defects – Illuminating the Mechanisms | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $1,791,765 | July 21, 2023 | April 30, 2028 | ZOHN, IRENE E | reporter.nih.gov |
| Cardiomyopathy Genomes Project | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,786,461 | May 1, 2015 | April 30, 2025 | MCNALLY, ELIZABETH M | reporter.nih.gov |
| 2/2 Percutaneous Intervention Versus Observational Trial of Arterial ductus management in Low-weight infants (PIVOTAL) Data Coordinating Center | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,778,031 | March 21, 2022 | February 28, 2027 | WISNIEWSKI, STEPHEN R | reporter.nih.gov |
| IntelliStent: A minimally Invasive, Adjustable Pulmonary Flow Restrictor System for Congenital and Acquired Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,771,084 | September 1, 2025 | August 31, 2027 | BOGNER, SETH ADAM | reporter.nih.gov |
| Developmental Progression of Youth with Critical Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,767,874 | April 1, 2020 | March 31, 2026 | VANNATTA, KATHRYN | reporter.nih.gov |
| Alcohol-induced cardiac injury and repair in human induced pluripotent stem cell model | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $1,760,250 | April 20, 2021 | March 31, 2027 | XU, CHUNHUI | reporter.nih.gov |
| Molecular Mechanisms of Atrial Development and Regeneration | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,759,486 | July 21, 2017 | December 31, 2026 | WAXMAN, JOSHUA | reporter.nih.gov |
| Cellular determinants of cardiopharyngeal multipotency and early fate choices | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,759,231 | August 1, 2011 | May 31, 2024 | MOGILNER, ALEXANDER | reporter.nih.gov |
| 1/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,758,207 | April 1, 2023 | March 31, 2030 | BACKES, CARL | reporter.nih.gov |
| Coding and Noncoding RNA Contributions to 22q11.2 Deletion Syndrome | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,737,187 | July 1, 2015 | June 30, 2026 | VAN OERS, NICOLAI STANISLAS CYRILLE | reporter.nih.gov |
| Shear stress and light-field to elucidate the initiation of cardiac outflow tract | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,736,801 | July 9, 2015 | December 31, 2025 | HSIAI, TZUNG K | reporter.nih.gov |
| Human Disease-Specific Induced Pluripotent Stem Cells For Preclinical Drug Testing and Drug Discovery | NIH | National Heart, Lung, and Blood Institute | 2022 | $1,728,439 | March 4, 2022 | February 28, 2023 | BUI, LYNNE A | reporter.nih.gov |
| Catheter Based Cardiovascular Device Retrieval System | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,708,264 | September 24, 2018 | June 30, 2024 | GORMAN, JOSEPH H | reporter.nih.gov |
| Congenital Heart Disease Genetics and Clinical Outcomes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,698,901 | September 30, 2009 | July 31, 2025 | BRUECKNER, MARTINA | reporter.nih.gov |
| Mechanism-inspired Strategies to Prevent Pathogenic Late Na Current in Cardiac Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,678,112 | February 17, 2023 | November 30, 2026 | JOHNY, MANU BEN | reporter.nih.gov |
| Bridging the Gap between Genomics and Clinical Outcomes in CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,669,113 | August 15, 2015 | July 31, 2025 | TRISTANI-FIROUZI, MARTIN | reporter.nih.gov |
| Deep Learning Based Phenotyping and Outcomes Prediction for Valvular Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,667,562 | May 1, 2024 | April 30, 2029 | OUYANG, DAVID | reporter.nih.gov |
| Potassium channels, membrane potential, and CHD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,661,160 | May 1, 2020 | April 30, 2024 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| ATF4 a Novel Regulator of Cardiac Development | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,634,704 | May 1, 2023 | April 30, 2027 | CHEN, JU | reporter.nih.gov |
| Evaluation of Hedgehog signaling-dependent heart development in a mouse model of Down Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,632,091 | December 26, 2022 | May 31, 2024 | MOSKOWITZ, IVAN PAUL | reporter.nih.gov |
| Modeling Cerebral Microbleeds and Striatal Brain Iron in Adult Congenital Heart Disease in Relationship to Differential Genetic Risk for Alzheimer Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,626,747 | June 1, 2020 | May 31, 2025 | CESCHIN, RAFAEL C | reporter.nih.gov |
| Gene therapy for long QT syndrome type 2 | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,622,218 | April 1, 2024 | March 31, 2028 | KOREN, GIDEON | reporter.nih.gov |
| Pharmacological Validation of Vascular KATP Channels for Modulating Ductus Arteriosus Tone | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $1,619,100 | September 1, 2020 | June 30, 2025 | DENTON, JEROD S. | reporter.nih.gov |
| The interaction of myosin and the thin filament: how mutations cause allosteric dysfunction and their connection to genetic cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,611,267 | December 15, 2010 | July 31, 2025 | TARDIFF, JIL C | reporter.nih.gov |
| Developmental and genetic function of SHROOM3 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,607,808 | March 1, 2023 | February 28, 2027 | WARE, STEPHANIE M | reporter.nih.gov |
| Mechanotransduction by Melusin in Cardiac Hypertrophy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,594,551 | July 1, 2020 | June 30, 2025 | SNIADECKI, NATHAN JOHN | reporter.nih.gov |
| Enhanced Imaging of the Fetal Brain Microstructure | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2024 | $1,579,200 | March 1, 2022 | June 30, 2024 | GHOLIPOUR-BABOLI, ALI | reporter.nih.gov |
| Mechanisms of outflow tract morphogenesis regulated by extracellular matrix | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,559,452 | June 1, 2023 | April 30, 2027 | TARGOFF, KIMARA L | reporter.nih.gov |
| Identifying unrecognized genetic causes of congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,545,594 | June 1, 2024 | March 31, 2028 | SEIDMAN, CHRISTINE E | reporter.nih.gov |
| Prenatal valve formation in congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,540,500 | June 1, 2023 | April 30, 2027 | RUGONYI, SANDRA | reporter.nih.gov |
| Cardiac MRI Increases Accuracy and Decreases Risk of Evaluation of Children with Cardiomyopathy and Cardiac Transplantation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,533,577 | February 15, 2019 | April 8, 2022 | OLIVIERI, LAURA J | reporter.nih.gov |
| Structure-function analysis for elucidating pathogenicity of cardiac ryanodine receptor genetic variants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,533,432 | July 1, 2019 | April 30, 2024 | MARKS, ANDREW ROBERT | reporter.nih.gov |
| A multi-physics simulator for pediatric cardiac surgical planning | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,528,043 | May 3, 2024 | April 30, 2029 | MARSDEN, ALISON L | reporter.nih.gov |
| Biomechanical Approaches and Technologies for Enhancing TAVR Outcomes | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2022 | $1,512,485 | September 15, 2018 | December 31, 2024 | BLUESTEIN, DANNY | reporter.nih.gov |
| Structure and Mechanism of the SET1/COMPASS H3K4 Methyltransferase Complex | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2024 | $1,511,693 | September 8, 2020 | July 31, 2025 | ZHENG, NING | reporter.nih.gov |
| Regulation of cardiomyocyte growth in a fetal ovine model of reduced left ventricular filling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,506,459 | July 1, 2024 | June 30, 2025 | JONKER, SONNET SKY | reporter.nih.gov |
| Dzip1 and Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,497,789 | June 1, 2020 | May 31, 2026 | NORRIS, RUSSELL | reporter.nih.gov |
| A multidisciplinary approach to understanding feedback and clustering in PCP signaling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,494,825 | April 1, 2024 | March 31, 2028 | AXELROD, JEFFREY D. | reporter.nih.gov |
| Injectable Biomaterial for Treating Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,478,164 | January 1, 2019 | December 31, 2023 | DAVIS, MICHAEL E | reporter.nih.gov |
| Role of RNA-binding protein DDX3X in heart development and disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,455,898 | July 1, 2024 | June 30, 2028 | DUBOIS, NICOLE | reporter.nih.gov |
| Pediatric Cardiopulmonary MRI using RF Navigators and High Dimensional Deep Learning | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,454,963 | July 1, 2024 | March 31, 2029 | JOHNSON, KEVIN MICHAEL | reporter.nih.gov |
| Amino-terminal acetylation of proteins in mammalian biology and disease | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,442,383 | September 1, 2019 | July 31, 2025 | LYON, GHOLSON | reporter.nih.gov |
| The Allogeneic Human Mesenchymal Stem Cell (MSCs) injection in Patients with Hypoplastic Left Heart Sydrome: A Phase IIb Clinical Trial (ELPIS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,435,351 | September 15, 2020 | August 31, 2025 | LAI, DEJIAN | reporter.nih.gov |
| SSRI Exposure and Ventricular Development from Bench to Bedside: A Prospective Study to Determine if Maternal Depression Treatment Impacts Offspring Cardiac Development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,427,056 | June 1, 2020 | May 31, 2026 | HASKELL, SARAH ELIZABETH | reporter.nih.gov |
| Molecular signaling in aortic valve development and congenital aortic valve defect | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $1,423,514 | January 1, 2022 | September 30, 2023 | ZHOU, BIN | reporter.nih.gov |
| Chromatin remodeling factor CHD7 regulates cardiac and craniofacial lymphatic vessel development | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,417,874 | July 25, 2024 | April 30, 2028 | LIEN, CHING-LING E | reporter.nih.gov |
| Mechanisms of morbidity after correcting aortic coarctations of varying severity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,415,421 | July 1, 2018 | April 30, 2028 | LADISA, JOHN FRANK | reporter.nih.gov |
| Kidney-Associated Diseases after Congenital Heart disease surgery In Children | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,396,868 | March 15, 2024 | January 31, 2028 | PARIKH, CHIRAG R | reporter.nih.gov |
| Identification of compensatory mechanisms to rescue aortic arch artery defects | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,395,644 | January 5, 2022 | December 31, 2026 | ASTROF, SOPHIE | reporter.nih.gov |
| Defining and perturbing gene regulatory dynamics in the developing human heart to understand mechanisms of congenital heart defects | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,395,117 | January 22, 2024 | December 31, 2027 | GREENLEAF, WILLIAM JAMES | reporter.nih.gov |
| Integrating Epidemiologic and Genomic Data to Elucidate the Genetic Overlap Between Congenital Anomalies and Pediatric Cancer | NIH | National Cancer Institute | 2023 to 2025 | $1,394,210 | September 19, 2023 | August 31, 2028 | HUFF, CHAD DANIEL | reporter.nih.gov |
| Define the mechanisms of aortopathy in bicuspid aortic valve patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,393,504 | April 13, 2018 | March 31, 2024 | YANG, BO | reporter.nih.gov |
| The role of Tie2 signaling in Aortic Valve Remodeling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,386,256 | August 10, 2024 | May 31, 2028 | BALDWIN, H SCOTT | reporter.nih.gov |
| Cardiovascular disease in fetal alcohol spectrum disorder | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $1,373,520 | August 10, 2022 | April 30, 2027 | BURNS, CAROLINE E | reporter.nih.gov |
| A Preclinical Study Evaluating and Comparing the Efficacy of Tissue Engineered Vascular Grafts to Polytetrafluoroethylene Grafts | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,370,291 | June 15, 2022 | May 31, 2027 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Safe and Effective MRI for Pediatric Patients with a Cardiac Implantable Electronic Device | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,357,652 | March 1, 2024 | February 29, 2028 | GOLESTANI RAD, LALEH | reporter.nih.gov |
| Perinatal cardiomyocyte pruning driven by metabolic maturation: Opportunity for intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,356,525 | March 15, 2019 | February 29, 2024 | JONKER, SONNET SKY | reporter.nih.gov |
| Multi-scale modeling of inherited pediatric cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,355,405 | September 1, 2017 | January 31, 2023 | PARKER, KEVIN KIT | reporter.nih.gov |
| Mechanisms for cell signaling in the control of cardiomyogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,352,193 | August 1, 2016 | August 31, 2026 | SONG, KUNHUA | reporter.nih.gov |
| Structural Mechanisms of Polycystic Kidney Disease Proteins | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,348,334 | July 22, 2024 | April 30, 2028 | CAO, ERHU | reporter.nih.gov |
| Molecular and cellular mechanisms in cardiac outflow tract formation and defects | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,344,518 | September 1, 2021 | September 30, 2023 | ZHOU, BIN | reporter.nih.gov |
| Mechanisms of de novo cardiac sarcomere assembly | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,334,378 | April 1, 2024 | March 31, 2028 | DUBOIS, NICOLE | reporter.nih.gov |
| Structural and functional basis of myocardial dysregulation in genetic cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,331,834 | June 15, 2024 | May 31, 2028 | KIRK, JONATHAN A | reporter.nih.gov |
| Mechanisms and Therapeutics for Congenital Aortic Valve Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,329,648 | July 5, 2024 | April 30, 2028 | GARG, VIDU | reporter.nih.gov |
| Biomechanics of Neural Tube Development using Brillouin-OCT Multimodality | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,329,503 | September 1, 2018 | June 30, 2024 | LARIN, KIRILL V | reporter.nih.gov |
| Role of integrin a5b1 in vascular patterning and the formation of the pharyngeal arch arteries | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,328,249 | July 1, 2010 | August 31, 2025 | ASTROF, SOPHIE | reporter.nih.gov |
| Fast and Accurate Cardiovascular MRI with Hyper 4D-Flow | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,314,238 | January 1, 2024 | December 31, 2027 | ENNIS, DANIEL B | reporter.nih.gov |
| Enabling the Assessment of Fetal Brain Development and Degeneration with Machine Learning | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2025 | $1,314,225 | June 1, 2023 | May 31, 2028 | KARIMI, DAVOOD | reporter.nih.gov |
| Role of the cardiac neural crest in development and regeneration | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,310,630 | December 15, 2023 | November 30, 2027 | BRONNER, MARIANNE | reporter.nih.gov |
| Transforming Care Delivery Models for at-Risk Young Adult Patients with Congenital Heart Disease and Amplifying Research Efforts to Improve Health Equity in Pediatric Chronic Disease Care | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,308,575 | June 18, 2024 | January 31, 2026 | LOPEZ, KEILA NATILDE | reporter.nih.gov |
| Heart rate control with bioengineered pacemakers | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,305,622 | June 5, 2021 | May 31, 2026 | CHO, HEE CHEOL | reporter.nih.gov |
| Decrypting Variants of Uncertain Significance in Long-QT Syndrome | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,297,448 | August 1, 2014 | July 31, 2027 | SANDERS, CHARLES R | reporter.nih.gov |
| Deciphering the Neonatal Cardiac Regenerative Potential and Regulators in Large Animals | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,248,298 | July 15, 2019 | June 30, 2025 | ZHANG, JIANYI | reporter.nih.gov |
| Mechanistic dissection of 22q11.2DS in zebrafish | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,242,466 | March 1, 2024 | February 29, 2028 | BURNS, CAROLINE E | reporter.nih.gov |
| Mechanistic clinical trial of Beta-blocker administration for reactivating cardiomyocyte division in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,233,399 | July 1, 2021 | April 30, 2027 | KUHN, BERNHARD | reporter.nih.gov |
| Molecular signaling in aortic valve development and congenital aortic valve defect | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,220,744 | January 1, 2022 | December 31, 2026 | ZHOU, BIN | reporter.nih.gov |
| Impact of Advanced Imaging and Enhanced Risk Profiling on Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,200,248 | September 1, 2024 | May 31, 2028 | MAY, HEIDI THOMAS | reporter.nih.gov |
| PRDM16 in cardiac development | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,184,792 | August 20, 2020 | April 30, 2024 | CHEN, JU | reporter.nih.gov |
| New Mechanisms of Heterotaxy and Congenital Heart Disease: Nucleoporins at Cilia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,184,170 | April 1, 2015 | November 30, 2023 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| Regulation of Cardiomyocyte Maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,177,576 | March 15, 2019 | January 31, 2023 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Congenital Heart Disease Expert Curation Panel | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $1,170,880 | August 1, 2022 | June 30, 2026 | ROBERTS, AMY E | reporter.nih.gov |
| Novel Gene-Environment Regulatory Circuit in Chamber-Specific Growth of Perinatal Heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,170,000 | September 1, 2020 | June 30, 2025 | TOUMA, MARLIN | reporter.nih.gov |
| Novel Signaling Mechanism in Chamber-Specific Postnatal Heart Growth | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,170,000 | June 1, 2023 | May 31, 2028 | YOKOTA, TOMOHIRO | reporter.nih.gov |
| Investigating altered smooth muscle cell mechanotransduction as a cause of supravalvular aortic stenosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,169,167 | December 1, 2022 | November 30, 2026 | WAGENSEIL, JESSICA | reporter.nih.gov |
| Electrical Stimulation of Human CPCs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,162,500 | February 10, 2020 | February 28, 2026 | MAXWELL, JOSHUA THOMAS | reporter.nih.gov |
| Multi-Site Validation Study of the HLHS Arrest Predictor | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,159,424 | July 1, 2018 | May 31, 2026 | RUSIN, CRAIG G | reporter.nih.gov |
| Modeling Gene Regulatory Networks for Early Cardiopharyngeal Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,153,555 | September 1, 2018 | August 31, 2024 | SATIJA, RAHUL | reporter.nih.gov |
| Readily Available Biological Conduits to Treat Single Ventricle Defects | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,147,128 | December 1, 2023 | November 30, 2027 | QYANG, YIBING | reporter.nih.gov |
| Glycosphingolipid-Mediated Cardiomyocyte and Immune Cell Dysfunction in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,142,202 | June 1, 2024 | April 30, 2029 | GARCIA, ANASTACIA M | reporter.nih.gov |
| Locking and Unlocking Cardiac Maturation | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,137,498 | April 1, 2025 | March 31, 2032 | KELLY, DANIEL PATRICK | reporter.nih.gov |
| Decoding the transcriptional mechanisms of pericardium formation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,129,649 | March 15, 2024 | February 28, 2028 | MOSIMANN, CHRISTIAN | reporter.nih.gov |
| Linking State Medicaid and Congenital Heart Surgical Registry Data: Building Capacity to Assess Disparities in Longitudinal Outcomes and Value for Children with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,111,167 | January 5, 2020 | September 1, 2023 | ANDERSON, BRETT ROMEO | reporter.nih.gov |
| Molecular and cellular mechanisms in cardiac outflow tract formation and defects | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,107,221 | September 1, 2021 | August 31, 2025 | ZHOU, BIN | reporter.nih.gov |
| Proteomic Profiling of Patent Foramen Ovale Related Neurovascular Injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $1,102,500 | July 1, 2010 | March 31, 2024 | NING, MINGMING | reporter.nih.gov |
| Non-selective Large Conductance Ion Channels In Triggered Arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,092,708 | April 1, 2024 | March 31, 2028 | KRYSHTAL, DMYTRO O. | reporter.nih.gov |
| Biomechanics of early mammalian cardiogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $1,086,902 | September 1, 2018 | June 30, 2024 | LARINA, IRINA | reporter.nih.gov |
| Regulation of cardiac power output in health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,070,114 | April 1, 2018 | March 31, 2024 | GREENBERG, MICHAEL J | reporter.nih.gov |
| Sodium Channels and Cardiac Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,064,606 | March 15, 2010 | July 31, 2024 | DESCHENES, ISABELLE | reporter.nih.gov |
| Quantification of the decline of heart muscle cell proliferation and its reversal in pediatric patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,064,006 | June 15, 2020 | January 31, 2024 | KUHN, BERNHARD | reporter.nih.gov |
| Baylor/Texas Children's Hospital Pediatric Heart Network | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,046,091 | January 1, 2017 | December 31, 2023 | PENNY, DANIEL J | reporter.nih.gov |
| Role of SR-mitochondria interplay in calcium-dependent arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,032,103 | January 8, 2024 | December 31, 2025 | LIU, BIN | reporter.nih.gov |
| Unraveling mechanisms of genome regulation to understand and improve human health | NIH | National Institute of General Medical Sciences | 2021 to 2023 | $1,023,089 | September 9, 2016 | June 30, 2024 | COTNEY, JUSTIN LEE | reporter.nih.gov |
| Pediatric Heart Network Regents of the University of Michigan | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,022,892 | January 1, 2017 | December 31, 2023 | GOLDBERG, CAREN S | reporter.nih.gov |
| Cyclophilin D Regulates Neonatal Cardiac Bioenergetics and Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,010,948 | July 15, 2019 | June 30, 2024 | PORTER, GEORGE A | reporter.nih.gov |
| Pediatric Heart Network Clinical Research Centers - Boston Children's Hospital | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $995,626 | January 1, 2024 | December 31, 2030 | DE FERRANTI, SARAH D | reporter.nih.gov |
| Development of Novel Compounds for Treatment of Heart Arrhythmias in CPVT | NIH | National Heart, Lung, and Blood Institute | 2021 | $971,323 | August 21, 2012 | November 30, 2023 | SHOTWELL, SANDRA LEE | reporter.nih.gov |
| Identifying and protecting alcohol-sensitive epigenetic changes in congenital heart disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2021 to 2025 | $960,407 | September 10, 2021 | August 31, 2026 | FORD, STEPHANIE MARIE | reporter.nih.gov |
| A hERG1 potassium channel subdomain is trafficked to the cardiac nucleus: mechanisms and targets of the hERG1NP | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $954,268 | July 1, 2024 | June 30, 2029 | JONES, DAVID K. | reporter.nih.gov |
| Pediatric Heart Network Emory University | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $951,177 | January 1, 2017 | December 31, 2023 | MAHLE, WILLIAM T | reporter.nih.gov |
| Pediatric Heart Network New York Consortium | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $948,011 | January 1, 2024 | December 31, 2030 | RICHMOND, MARC ERIC | reporter.nih.gov |
| Bicuspid Aortic Valve Biomechanics and Calcification | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $937,996 | March 1, 2024 | February 29, 2028 | LINCOLN, JOY | reporter.nih.gov |
| Microphysiology Systems Database Supplement to Tissue Chips for Precision Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia-Supplement | NIH | National Center for Advancing Translational Sciences | 2021 | $932,065 | August 1, 2020 | June 30, 2022 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Unraveling molecular Complexity of Mitral Valve Disease using single cell and Spatial Multi-Omics analysis" | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $924,266 | September 1, 2024 | June 30, 2028 | LIU, YANG | reporter.nih.gov |
| Assessing and Promoting Resilience in Adults with Adult Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $919,866 | December 3, 2020 | November 30, 2026 | STEINER, JILL MARIE | reporter.nih.gov |
| Simulating Cardiac Surgery for Children with Severe Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $919,196 | January 3, 2020 | April 30, 2024 | HEDJAZI MOGHARI, MEHDI | reporter.nih.gov |
| 1/2 CORD-CHD: Clamp OR Delay among neonates with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2023 | $907,257 | April 1, 2023 | March 31, 2024 | BACKES, CARL | reporter.nih.gov |
| Pediatric Heart Network Joint Heart Program Consortium | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $903,977 | January 1, 2024 | December 31, 2030 | CNOTA, JAMES | reporter.nih.gov |
| lntegration and Visualization of Diverse Biological Data | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $896,588 | April 1, 2005 | March 31, 2024 | TROYANSKAYA, OLGA G | reporter.nih.gov |
| Imaging early development of human neural circuits | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $894,347 | August 16, 2022 | June 30, 2024 | GHOLIPOUR-BABOLI, ALI | reporter.nih.gov |
| Unraveling mechanisms of genome regulation to understand and improvehuman health | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $890,000 | September 9, 2016 | July 31, 2027 | COTNEY, JUSTIN LEE | reporter.nih.gov |
| Novel Zinc-Nanocomposite Materials for Pediatric Bioresorbable Cardiovascular Stents | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $868,304 | July 1, 2019 | June 30, 2025 | LINSLEY, CHASE | reporter.nih.gov |
| Pediatric Heart Network University of Michigan | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $867,553 | January 22, 2024 | December 31, 2030 | GOLDBERG, CAREN S | reporter.nih.gov |
| Pediatric Heart Network (PHN) - Utah Center | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $866,234 | January 8, 2024 | December 31, 2030 | WILLIAMS, RICHARD VINCENT | reporter.nih.gov |
| Developing a spatiotemporal lineage map of heart development | NIH | National Heart, Lung, and Blood Institute | 2025 | $865,286 | August 1, 2025 | June 30, 2029 | PU, WILLIAM TSWENCHING | reporter.nih.gov |
| Mechanism of LV Hypoplasia in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 | $835,541 | July 1, 2018 | April 30, 2023 | TSANG, MICHAEL WAIKOK | reporter.nih.gov |
| Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation: A Comparative Study of Clinical Outcomes, Patient Experiences, and Mechanistic Insights with Multimodality Imaging | NIH | National Heart, Lung, and Blood Institute | 2024 | $834,249 | August 1, 2024 | July 31, 2026 | GUPTA, AAKRITI | reporter.nih.gov |
| Imaging early development of human neural circuits | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $830,676 | August 1, 2024 | July 31, 2027 | GHOLIPOUR-BABOLI, ALI | reporter.nih.gov |
| The electrophysiological properties of embryos | NIH | National Heart, Lung, and Blood Institute | 2024 | $817,424 | July 1, 2024 | June 30, 2028 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| Modulation of KCNQ1 channel activity | NIH | National Institute of General Medical Sciences | 2021 to 2022 | $816,636 | May 1, 2014 | December 31, 2023 | LARSSON, HANS PETER | reporter.nih.gov |
| Mesenchymal Stromal Cell Delivery through Cardiopulmonary Bypass in Pediatric Cardiac Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 | $813,164 | May 21, 2019 | April 30, 2024 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| 1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL) | NIH | National Heart, Lung, and Blood Institute | 2022 | $812,264 | March 21, 2022 | February 28, 2023 | BACKES, CARL | reporter.nih.gov |
| Calcium and the physiology of diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2022 | $810,000 | May 1, 2019 | February 29, 2024 | MARKS, ANDREW ROBERT | reporter.nih.gov |
| Calcium Release Channel Deficiency Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $807,000 | June 1, 2024 | March 31, 2028 | ACKERMAN, MICHAEL JOHN | reporter.nih.gov |
| Ubiquitin Regulation of K Channels in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $805,851 | April 1, 2018 | February 28, 2022 | COLECRAFT, HENRY M. | reporter.nih.gov |
| Interpreting coding/non-coding variants for congenital heart disease through gene regulatory networks | NIH | National Heart, Lung, and Blood Institute | 2025 | $802,762 | February 1, 2025 | December 31, 2028 | HON, GARY CHUNG | reporter.nih.gov |
| Molecular regulation of ventricular chamber maturation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $798,709 | February 15, 2018 | January 31, 2024 | LIU, JIANDONG | reporter.nih.gov |
| Oligo-Vascular Crosstalk in the Developing Brain: Implications for White Matter Injury in Congenital Heart Disease | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2024 | $795,238 | July 15, 2020 | June 30, 2025 | CHAVALI, MANIDEEP | reporter.nih.gov |
| A population-based computational approach for arrhythmia prediction and therapy | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $787,500 | July 9, 2024 | June 30, 2028 | QU, ZHILIN | reporter.nih.gov |
| Metabolic regulation of heart formation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $780,000 | June 1, 2019 | May 31, 2023 | NAKANO, ATSUSHI | reporter.nih.gov |
| Placental hemodynamic effects on brain development in infants with congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $777,536 | September 1, 2022 | August 31, 2027 | LEON, RACHEL L | reporter.nih.gov |
| Functional characterization of genes and genetic variants associated with hypoplastic heart syndrome in Drosophila | NIH | National Heart, Lung, and Blood Institute | 2025 | $777,016 | August 1, 2025 | May 31, 2029 | HAN, ZHE | reporter.nih.gov |
| COMPASS Ancillary NeuroDevelopmental Outcomes(CAN-DO) | NIH | National Heart, Lung, and Blood Institute | 2025 | $776,754 | July 15, 2025 | April 30, 2030 | WOLFE, KELLY R | reporter.nih.gov |
| Renal Fitness in Young Adults with Congenital Heart Disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $773,082 | June 1, 2019 | September 30, 2025 | FUHRMAN, DANA YOUNG | reporter.nih.gov |
| Phase II: Rapid Array Diagnosis of Congenital Heart Defects (RAD4CHD) Using Allele Diagnostics Rapid Array Chromosomal Microarray Strategy | NIH | National Heart, Lung, and Blood Institute | 2021 | $768,564 | March 1, 2019 | May 31, 2022 | TORCHIA, BETH | reporter.nih.gov |
| Epigenetic Mechanisms Underlying Maternal Diabetes Associated Cardiac Malformations | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $760,000 | August 20, 2019 | July 31, 2025 | GARG, VIDU | reporter.nih.gov |
| The role of RNA binding proteins in heart development and congenital heart defects | NIH | National Heart, Lung, and Blood Institute | 2022 | $759,511 | May 12, 2022 | February 7, 2023 | KUYUMCU-MARTINEZ, MUGE NESLIHAN | reporter.nih.gov |
| Decoupling mitral valve-left ventricular fibrotic remodeling in degenerative mitral regurgitation via serotonin 2B receptor | NIH | National Heart, Lung, and Blood Institute | 2025 | $759,030 | September 1, 2025 | May 31, 2029 | MERRYMAN, WILLIAM D | reporter.nih.gov |
| Improving transitions of care for adults with congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $756,984 | September 8, 2022 | August 31, 2027 | AGARWAL, ANUSHREE | reporter.nih.gov |
| TET-mediated epigenetic regulation in cardiac development. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $751,928 | February 15, 2018 | March 31, 2023 | HUANG, YUN | reporter.nih.gov |
| Functional dissection of the regulatory network that governs cardiomyocyte maturation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $747,000 | September 1, 2022 | August 31, 2025 | VANDUSEN, NATHAN JAMES | reporter.nih.gov |
| The Effects of Estrogen on Cardiac Arrhythmic Propensity | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $745,035 | February 10, 2023 | January 31, 2026 | ITZHAKI, ILANIT | reporter.nih.gov |
| Cell Therapy for Neuroprotection in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $735,704 | December 15, 2017 | April 30, 2027 | ISHIBASHI, NOBUYUKI | reporter.nih.gov |
| Biomechanical indicators of bicuspid aortic valve dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 | $716,097 | June 1, 2018 | May 31, 2023 | SACKS, MICHAEL S | reporter.nih.gov |
| Functional Cardiovascular 4D MRI in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $709,759 | September 1, 2012 | March 31, 2024 | MARKL, MICHAEL | reporter.nih.gov |
| Pediatric Heart Network - GATHER - between Washington University in St Louis and Children's Hospital Colorado | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $708,907 | January 1, 2024 | December 31, 2030 | GLATZ, ANDREW CHARLES | reporter.nih.gov |
| AI Driven End-to-End 4D flow MRI Pipeline for Hemodynamic Assessment in BAV Disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $704,234 | August 5, 2025 | May 31, 2030 | MARKL, MICHAEL | reporter.nih.gov |
| Regional specific metabolism regulates specification of the Spemann Organizer | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $703,250 | July 10, 2024 | May 2, 2025 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2 | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $702,491 | September 1, 2023 | February 28, 2025 | AUERBACH, DAVID SCOTT | reporter.nih.gov |
| CDK13 function in heart development and congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2025 | $701,842 | August 1, 2025 | June 30, 2029 | WANG, DA-ZHI | reporter.nih.gov |
| Pulmonary vascular glutamine metabolism at the intersection of hemodynamic forces and smooth muscle proliferation in congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $699,192 | August 15, 2020 | July 31, 2025 | BOEHME, JASON | reporter.nih.gov |
| Artificial Intelligence assisted echocardiography to facilitate optimal image extraction for congenital heart defects diagnosis in Sub-Saharan Africa | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $698,589 | September 20, 2023 | March 31, 2027 | LEKE, AMINKENG ZAWUO | reporter.nih.gov |
| ROS mechanisms in BAV aortopathy | NIH | National Heart, Lung, and Blood Institute | 2021 | $696,823 | July 1, 2021 | June 30, 2025 | GLEASON, THOMAS GILLETTE | reporter.nih.gov |
| Frailty, Aging, and Risk of Adverse Outcomes in Mitral Valve Prolapse (FAR-OUT-MVP Study) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $691,163 | July 1, 2019 | August 31, 2024 | STROM, JORDAN BLAIR | reporter.nih.gov |
| A Study Implementing Models for Mechanical Circulatory Support Presurgical Assessment in Congenital Heart Disease Treatment (IMMPACT) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $683,424 | August 25, 2022 | July 31, 2027 | FAROOQI, KANWAL MAJEED | reporter.nih.gov |
| Novel pathogenesis of LVNC | NIH | National Heart, Lung, and Blood Institute | 2025 | $683,048 | May 1, 2025 | March 31, 2030 | LI, DEQIANG | reporter.nih.gov |
| Impact of Blood Viscosity and Vascular Compliance on Fontan Circulation Dysfunction in Children | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $679,188 | March 1, 2022 | February 28, 2027 | CHENG, ANDREW L | reporter.nih.gov |
| Dzip1 and Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2025 | $678,380 | June 1, 2020 | August 31, 2026 | NORRIS, RUSSELL | reporter.nih.gov |
| Novel Cardiac MRI-Based Predictors for Tetralogy of Fallot: Deformation, Kinematic, and Geometric Analyses | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $677,485 | February 15, 2021 | January 31, 2027 | TANDON, ANIMESH | reporter.nih.gov |
| Optical Functional Neuroimaging of Acute and Chronic Hypoxia | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $674,360 | July 1, 2020 | June 30, 2025 | WHITE, BRIAN RICHARD | reporter.nih.gov |
| The Impact of Public Reporting on Procedural Outcomes Following Congenital Heart Surgery | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $673,598 | January 28, 2022 | December 31, 2026 | JAYARAM, NATALIE | reporter.nih.gov |
| Integration of RNA and Genome Sequences to Identify Genetic Risk in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $671,600 | July 1, 2022 | June 30, 2027 | MORTON, SARAH UHLER | reporter.nih.gov |
| Inflammatory and Genetic Cardiomyopathies: Metabolic Phenotyping to Guide Diagnosis and Therapy | NIH | National Heart, Lung, and Blood Institute | 2025 | $663,578 | August 15, 2025 | May 31, 2029 | NAZER, BABAK | reporter.nih.gov |
| Senescent Cell States in Single Ventricle Disease with Heart Failure | NIH | National Heart, Lung, and Blood Institute | 2025 | $655,636 | January 1, 2025 | July 31, 2025 | MARTIN, JAMES F | reporter.nih.gov |
| Molecular and Functional Evaluation of NOTCH1 Deficient iPSC Derived Cardiomyocytes in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $644,544 | March 10, 2022 | February 28, 2027 | SARAF, ANITA | reporter.nih.gov |
| Patient specific 3D printed tissue engineered vascular graft for aortic reconstruction designed by artificial intelligence algorithm. | NIH | National Heart, Lung, and Blood Institute | 2021 | $643,908 | July 1, 2018 | March 31, 2023 | HIBINO, NARUTOSHI | reporter.nih.gov |
| Hemodynamic Flow-Mediated Myocardial Reprogramming Impacts Cardiac Development | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $642,586 | July 15, 2018 | May 31, 2024 | CHI, NEIL C | reporter.nih.gov |
| Nuclear transport of developmental signaling effectors | NIH | National Heart, Lung, and Blood Institute | 2025 | $630,169 | August 20, 2025 | May 31, 2029 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| Coupling gene regulatory and lineage analysis of the cardiac neural crest | NIH | National Heart, Lung, and Blood Institute | 2021 | $623,632 | August 15, 2018 | May 31, 2023 | BRONNER, MARIANNE | reporter.nih.gov |
| "SHROOM3 is a Novel Cause of Congenital Heart Disease" | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $620,992 | July 7, 2020 | June 30, 2026 | DURBIN, MATTHEW D. | reporter.nih.gov |
| The electrophysiological properties of embryos Transfer | NIH | National Heart, Lung, and Blood Institute | 2025 | $612,607 | April 1, 2025 | April 30, 2028 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| Fetal Electrophysiologic Abnormalities in High-risk Pregnancies Associated with Fetal Demise | NIH | National Heart, Lung, and Blood Institute | 2021 | $611,689 | July 1, 2018 | October 31, 2024 | STRASBURGER, JANETTE F | reporter.nih.gov |
| Patterning Mechanisms for Ventricular Septation and Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2024 | $605,275 | September 19, 2024 | August 31, 2026 | KATHIRIYA, IRFAN S | reporter.nih.gov |
| Remotely Delivered Cardiac Rehabilitation for Adolescents with Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $603,786 | July 15, 2022 | June 30, 2027 | WHITE, DAVID A | reporter.nih.gov |
| Investigation of hepatic factor in pulmonary arteriovenous malformations | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $601,768 | April 1, 2022 | March 31, 2027 | SPEARMAN, ANDREW D | reporter.nih.gov |
| Mobile Diagnosis of Congenital Genetic Conditions: A Model for Screening and Surveillance in Low-Resource Settings | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $601,018 | February 1, 2024 | January 31, 2027 | VILAIN, ERIC J. | reporter.nih.gov |
| Pediatric Heart Network Emory University | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $600,907 | January 1, 2024 | December 31, 2030 | MAHLE, WILLIAM T | reporter.nih.gov |
| An Engineered Human Ductus Arteriosus Capable of Biomimetic Response to Vasoactive Agents | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $590,565 | September 1, 2025 | May 31, 2030 | SHELTON, ELAINE L. | reporter.nih.gov |
| Ultrasound System for Transational Research | NIH | Office of the Director, National Institutes of Health | 2021 | $589,686 | September 15, 2021 | September 14, 2022 | SINUSAS, ALBERT J | reporter.nih.gov |
| Machine learning approach to non-invasive MRI-based blood oximetry | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 | $587,783 | September 21, 2021 | September 20, 2025 | VARGHESE, JULIET J. | reporter.nih.gov |
| Influence of placental impairments and maternal-fetal environment on neurodevelopmental outcomes in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $587,732 | August 10, 2020 | June 30, 2025 | RAJAGOPALAN, VIDYA | reporter.nih.gov |
| Multiscale modeling of inherited cardiomyopathies and therapeutic interventions | NIH | National Heart, Lung, and Blood Institute | 2021 | $579,690 | August 3, 2017 | January 31, 2023 | CAMPBELL, KENNETH S | reporter.nih.gov |
| Novel tau-based diagnostics for neonatal hypoxic-ischemic injury | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2023 | $570,240 | September 30, 2019 | August 31, 2024 | HEFTI, MARCO MATTHIAS | reporter.nih.gov |
| Signaling by Shp2 mutants in RASopathies | NIH | National Heart, Lung, and Blood Institute | 2021 | $561,333 | April 1, 2018 | February 28, 2022 | BENNETT, ANTON M | reporter.nih.gov |
| Pulmonary Vascular Development in Single Ventricle Heart Disease: A Longitudinal Biomarker Approach | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $560,550 | January 1, 2023 | December 31, 2027 | FRANK, BENJAMIN S | reporter.nih.gov |
| Development of a Biomimetic Stentless Pulmonary Heart Valve for the Treatment of Pediatric Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2023 | $553,838 | May 1, 2023 | October 31, 2024 | D'AMORE, ANTONIO | reporter.nih.gov |
| Cardiac interaction networks as determinants of transcriptional specificity | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $549,565 | September 1, 2017 | May 31, 2023 | CONLON, FRANK LEO | reporter.nih.gov |
| Regional specific metabolism regulates specification of the Spemann Organizer | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2025 | $546,171 | July 10, 2024 | June 30, 2029 | KHOKHA, MUSTAFA K | reporter.nih.gov |
| A Tailored mHealth Vaping Prevention Intervention for Adolescents with Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $542,424 | August 15, 2023 | July 31, 2028 | FOX, KRISTEN R. | reporter.nih.gov |
| The role Akirin and Pannier interactions during myogenesis | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $542,000 | April 15, 2022 | March 31, 2027 | NOWAK, SCOTT JAMES | reporter.nih.gov |
| Transcriptional control of endocardial-specific gene expression | NIH | National Heart, Lung, and Blood Institute | 2025 | $540,856 | December 15, 2024 | November 30, 2028 | BLACK, BRIAN L | reporter.nih.gov |
| Role of Valve-Mediated Hemodynamics on Bicuspid Aortopathy | NIH | National Heart, Lung, and Blood Institute | 2021 | $526,338 | May 1, 2017 | April 30, 2023 | BARKER, ALEXANDER J. | reporter.nih.gov |
| Differential Shear Forces on Endocardial Endothelial Cells Regulate a Fibrotic Spectrum in the Left Ventricular Outflow Tract | NIH | National Heart, Lung, and Blood Institute | 2021 | $520,702 | July 1, 2018 | May 31, 2023 | GRANDE-ALLEN, KATHRYN JANE | reporter.nih.gov |
| A Novel Personalized Flow Modeling Paradigm for Fetal Aorta and Its Validation with Fetal Cardiac MRI | NIH | National Institute of Biomedical Imaging and Bioengineering | 2024 | $516,556 | September 18, 2024 | August 31, 2027 | WEI, ZHENGLUN ALAN | reporter.nih.gov |
| Towards Precision Medicine for Thoracic Aortic Disease: Defining the Clinical and Genomic Drivers of Bicuspid Aortopathy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $513,639 | May 1, 2023 | April 30, 2028 | GLOTZBACH, JASON PAUL | reporter.nih.gov |
| Multi-Lineage Modulation of cardiac neural crest cells during cardiac development | NIH | National Heart, Lung, and Blood Institute | 2024 | $506,984 | September 24, 2024 | August 31, 2025 | LIN, JIUANN-HUEY IVY | reporter.nih.gov |
| RSV I-PREP: Improving Evidence-Based Implementation of RSV Immuno-Prophylaxis Within Ethical and Policy Contexts | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $505,440 | August 1, 2023 | May 31, 2028 | SAPER, JENNIFER KUSMA | reporter.nih.gov |
| miRNA buffering mechanisms and phenotypic variability in genetic syndromes | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $500,500 | July 17, 2024 | June 30, 2026 | ZOHN, IRENE E | reporter.nih.gov |
| Commercialization Readiness for Ductus Arteriosus Stent to Improve Congenital Heart Defect Mortality | NIH | National Heart, Lung, and Blood Institute | 2024 | $500,000 | September 15, 2024 | August 31, 2025 | TANG, BEVERLY | reporter.nih.gov |
| Structural and Pharmacological Study of the KCNQ1/KCNE1 Potassium Channel Complex | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $498,000 | July 12, 2018 | December 31, 2023 | SUN, JI | reporter.nih.gov |
| Electrical excitability in vascular smooth muscle: from rare disease to new paradigms | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $497,998 | June 1, 2022 | May 31, 2025 | MCCLENAGHAN, CONOR | reporter.nih.gov |
| Longitudinal Assessment of Cerebrovascular Autoregulation (CA) and Associations to Neurodevelopmental Delays in Infants and Toddlers with and without Congenital Heart Disease (CHD) | NIH | National Institute of Nursing Research | 2021 to 2023 | $496,884 | August 27, 2021 | June 30, 2025 | TRAN, NHU | reporter.nih.gov |
| DUCTUS ARTERIOSUS STENT TO IMPROVE CONGENITAL HEART DEFECT MORTALITY | NIH | National Heart, Lung, and Blood Institute | 2021 | $492,571 | August 6, 2021 | July 31, 2022 | TANG, BEVERLY | reporter.nih.gov |
| Machine Learning for CCHD Screening using Dynamic Data | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2025 | $490,471 | March 10, 2023 | February 28, 2027 | SIEFKES, HEATHER M | reporter.nih.gov |
| Random Field Methods for integrative genomic analysis and high-dimensional risk prediction of congenital heart defects | NIH | National Heart, Lung, and Blood Institute | 2023 | $487,567 | September 8, 2023 | August 31, 2025 | LI, MING | reporter.nih.gov |
| Cardiac MRI increases accuracy and decreases risk of evaluation of children with cardiomyopathy and cardiac transplantation | NIH | National Heart, Lung, and Blood Institute | 2023 | $486,915 | February 15, 2019 | November 30, 2025 | OLIVIERI, LAURA J | reporter.nih.gov |
| Does Altered Brain Connectivity Correlate with Developmental Outcomes and Executive Function in Congenital Heart Disease? | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $486,774 | July 1, 2024 | June 30, 2027 | CHUNG, AI WERN | reporter.nih.gov |
| The role of damage-associated molecular patterns in perioperative morbidities and mortalities of pediatric congenital heart diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $486,750 | August 1, 2022 | July 31, 2025 | YUKI, KOICHI | reporter.nih.gov |
| Mediator complex in cardiac development and function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $486,648 | July 1, 2020 | June 30, 2023 | FANG, XI | reporter.nih.gov |
| Integrating imaging and computation to characterize neural crest cells in the myocardial development and regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $483,652 | September 4, 2020 | August 31, 2024 | DING, YICHEN | reporter.nih.gov |
| Defining New Pathways for Complex Human Heart Failure and Arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $482,760 | April 20, 2020 | March 31, 2025 | BRADLEY, ELISA ANN | reporter.nih.gov |
| Integrative Genomic Analysis of Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $481,162 | April 1, 2020 | March 31, 2023 | JIN, SHENG CHIH | reporter.nih.gov |
| Role of integrin a5b1 in vascular patterning and the formation of the pharyngeal arch arteries | NIH | National Heart, Lung, and Blood Institute | 2021 | $478,279 | July 1, 2010 | August 31, 2022 | ASTROF, SOPHIE | reporter.nih.gov |
| Computational Modeling of Right Ventricular Intracardiac Flow in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $477,250 | December 15, 2020 | November 30, 2023 | LOKE, YUE-HIN | reporter.nih.gov |
| Enhanced Imaging of the Fetal Brain Microstructure | NIH | National Institute of Biomedical Imaging and Bioengineering | 2025 | $469,574 | March 1, 2022 | December 31, 2026 | GHOLIPOUR-BABOLI, ALI | reporter.nih.gov |
| The Role of YAP1:TEAD Enhancers in the Retinoic Acid-Regulatory Network of Cardiac Progenitors | NIH | National Heart, Lung, and Blood Institute | 2022 | $468,721 | September 12, 2022 | August 31, 2024 | ESTARAS, CONCEPCION | reporter.nih.gov |
| Identification of compensatory mechanisms to rescue aortic arch artery defects | NIH | National Heart, Lung, and Blood Institute | 2022 | $468,337 | January 5, 2022 | December 31, 2022 | ASTROF, SOPHIE | reporter.nih.gov |
| Role of RAF1 in human cardiogenesis and congenital heart defects | NIH | National Heart, Lung, and Blood Institute | 2023 | $467,728 | September 23, 2023 | August 31, 2024 | JAFFRÉ, FABRICE | reporter.nih.gov |
| Simulating Cardiac Surgery for Children with Severe Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $466,872 | January 3, 2020 | April 30, 2021 | HEDJAZI MOGHARI, MEHDI | reporter.nih.gov |
| Developing a CRISPR-based forward-genetic screening method in embryonic zebrafish | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $449,350 | August 1, 2019 | August 31, 2027 | HILL, JONATHON T | reporter.nih.gov |
| DEVELOPMENT OF A PULMONARY FLOW RESTRICTOR FOR HYPOPLASTIC LEFT HEART SYNDROME | NIH | National Heart, Lung, and Blood Institute | 2022 | $448,000 | February 15, 2022 | January 31, 2023 | TANG, BEVERLY | reporter.nih.gov |
| Novel mitochondria-targeting peptides (MTPs) as therapeutic intervention in Barth syndrome | NIH | National Heart, Lung, and Blood Institute | 2025 | $445,500 | January 15, 2025 | December 31, 2027 | SANDLERS, YANA I | reporter.nih.gov |
| Role of congenital heart defects in motor skills and language acquisition of infants with Down syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 to 2025 | $441,846 | June 1, 2024 | May 31, 2027 | WU, JIANHUA | reporter.nih.gov |
| NOTCH signaling on the underdeveloped cardiac vascularization of hypoplastic left heart syndrome in the hiPSC-derived vascularized cardiac organoids | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $438,157 | September 8, 2022 | August 31, 2025 | YANG, HUAXIAO | reporter.nih.gov |
| Toward Patient-Specific Computational Modeling of Tricuspid Valve Repair in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $436,901 | September 1, 2023 | August 31, 2027 | WU, WENSI | reporter.nih.gov |
| An Integrated and Automated Tool for Quantification of Biomechanics in Fetal and Neonatal Echocardiography | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2023 | $431,893 | September 15, 2022 | August 31, 2025 | VLACHOS, PAVLOS P | reporter.nih.gov |
| A growth-accommodating transcatheter pulmonary valve system for young children | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $431,750 | July 7, 2021 | June 30, 2024 | KHERADVAR, ARASH | reporter.nih.gov |
| Mechanisms of second heart field development regulated by Nkx genes | NIH | National Heart, Lung, and Blood Institute | 2021 | $429,539 | January 1, 2017 | December 31, 2023 | TARGOFF, KIMARA L | reporter.nih.gov |
| Dissecting SARS-CoV-2 infection in Down syndrome with congenital heart defects using patient-specific iPSCs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $429,000 | September 6, 2022 | July 31, 2025 | ZHAO, MINGTAO | reporter.nih.gov |
| Brain Metabolites, Brain Antioxidant, and Cerebral Blood Flow Deficits in Single Ventricle Heart Disease | NIH | National Institute of Neurological Disorders and Stroke | 2023 to 2024 | $429,000 | February 1, 2023 | January 31, 2026 | KUMAR, RAJESH | reporter.nih.gov |
| Potassium channels and uteroplacental vessels function in pregnant long QT type 1 women | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $427,625 | March 8, 2023 | February 28, 2026 | LORCA, RAMON A | reporter.nih.gov |
| Disparities in the effect of state policy for the newborn screening for critical congenital heart diseases | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $423,775 | September 23, 2021 | August 31, 2024 | SAKAI-BIZMARK, RIE | reporter.nih.gov |
| Exploring the role of mitochondria in dysregulated calcium handling in diseased hearts | NIH | National Heart, Lung, and Blood Institute | 2021 | $422,652 | June 10, 2021 | May 31, 2024 | LIU, BIN | reporter.nih.gov |
| Defining the spatio-temporal mechanisms of ventricular cell specification and differentiation | NIH | National Heart, Lung, and Blood Institute | 2021 | $421,237 | February 15, 2018 | January 31, 2023 | DUBOIS, NICOLE | reporter.nih.gov |
| Heart rate control with bioengineered pacemakers | NIH | National Heart, Lung, and Blood Institute | 2021 | $415,881 | June 5, 2021 | January 31, 2022 | CHO, HEE CHEOL | reporter.nih.gov |
| Mechanisms of cardiomyocyte-extracellular matrix interactions in cardiogenesis | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $411,542 | September 1, 2021 | August 31, 2025 | SCHUMACHER, JENNIFER | reporter.nih.gov |
| Multi-center, randomized, controlled trial of the feasibility and safety of inhaled hydrogen gas during ECPR | NIH | National Heart, Lung, and Blood Institute | 2022 | $410,558 | September 1, 2022 | August 31, 2023 | KHEIR, JOHN NAGI | reporter.nih.gov |
| Transformation of metal oxide nanomaterials in wildland-urban interface fires causes congenital heart disease | NIH | National Institute of Environmental Health Sciences | 2025 | $409,750 | January 18, 2025 | January 17, 2027 | AZHAR, MOHAMAD | reporter.nih.gov |
| Mobile Diagnosis of Congenital Genetic Conditions: A Model for Screening and Surveillance in Low-Resource Settings | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $409,475 | September 1, 2021 | January 31, 2024 | LINGURARU, MARIUS GEORGE | reporter.nih.gov |
| Regulation of cardiac patterning via Akirin/NuRD Interactions | NIH | National Heart, Lung, and Blood Institute | 2022 | $406,267 | September 5, 2022 | August 31, 2025 | BRYANTSEV, ANTON | reporter.nih.gov |
| Development of a Genetic Rabbit Model of Kcnh2-Mediated Epilepsy, SUDEP, & Long QT Syndrome Type 2 | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $405,611 | September 1, 2023 | August 31, 2026 | AUERBACH, DAVID SCOTT | reporter.nih.gov |
| Development and Validation of a High-Fidelity Cardiac Presurgical Planning Platform for Congenital Heart Defects Using 3D Printing Technology | NIH | National Heart, Lung, and Blood Institute | 2025 | $400,016 | September 10, 2025 | May 9, 2027 | KELLY, TYLER | reporter.nih.gov |
| Personalized Computational Modeling for Predicting Hemodynamics in Borderline Left Ventricles | NIH | National Library of Medicine | 2024 to 2025 | $397,943 | August 7, 2024 | July 31, 2026 | VEDULA, VIJAY | reporter.nih.gov |
| Retinoic acid-dependent epigenetic and transcriptional mechanisms controlling heart development | NIH | National Heart, Lung, and Blood Institute | 2021 | $397,500 | February 1, 2018 | January 31, 2023 | WAXMAN, JOSHUA | reporter.nih.gov |
| Rtf1-dependent transcriptional regulation of heart development | NIH | National Heart, Lung, and Blood Institute | 2021 | $394,500 | July 1, 2018 | April 30, 2023 | CHEN, JAU-NIAN | reporter.nih.gov |
| Functional screen for genetic causes of hypoplastic left heart syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $390,901 | April 1, 2023 | March 31, 2026 | NIE, SHUYI | reporter.nih.gov |
| Electrical stimulation of human CPCs | NIH | National Heart, Lung, and Blood Institute | 2021 | $390,000 | February 10, 2020 | August 30, 2021 | MAXWELL, JOSHUA THOMAS | reporter.nih.gov |
| KCNJ2-Induced Arrhythmia Mechanisms in CPVT and Heart Failure. | NIH | National Heart, Lung, and Blood Institute | 2021 | $381,228 | August 1, 2018 | July 31, 2023 | ECKHARDT, LEE LOCHBAUM | reporter.nih.gov |
| Investigating the role of H2A.Z dynamics in regulating cardiac lineage commitment | NIH | National Heart, Lung, and Blood Institute | 2021 | $380,935 | February 1, 2018 | January 31, 2024 | BOYER, LAURIE A | reporter.nih.gov |
| Patient Specific Tissue Engineered Vascular Graft Creation Using 3D Printing Technology | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $372,963 | January 1, 2017 | December 31, 2022 | HIBINO, NARUTOSHI | reporter.nih.gov |
| Computational Prioritization of Coding and Non-Coding Variants in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $370,856 | September 1, 2021 | August 31, 2024 | MORTON, SARAH | reporter.nih.gov |
| Physiologic and Genetic Contributions of Impaired Fetal Brain Development in Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $363,388 | April 1, 2019 | March 31, 2023 | ORTINAU, CYNTHIA MARIE | reporter.nih.gov |
| Optimizing Congenital Aortic Valve Surgery with Simulation-Guided Design | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $363,264 | August 16, 2024 | July 31, 2029 | KAISER, ALEXANDER D | reporter.nih.gov |
| Uncovering the DNA recognition rules of cardiac transcription factors | NIH | National Institute of General Medical Sciences | 2021 | $356,820 | June 1, 2018 | May 31, 2025 | RODRIGUEZ-MARTINEZ, JOSE A | reporter.nih.gov |
| Fetal Brain Development in Congenital Heart Disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $351,833 | January 1, 2022 | December 31, 2022 | ROLLINS, CAITLIN | reporter.nih.gov |
| An automated system to interpret echocardiography to predict adverse outcomes in patients with right ventricular dysfunction in daily hospital practice | NIH | National Heart, Lung, and Blood Institute | 2021 | $346,545 | August 15, 2021 | July 31, 2023 | SCHILLING, JAMES W | reporter.nih.gov |
| 1/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) – CCC | NIH | National Heart, Lung, and Blood Institute | 2024 | $342,731 | July 1, 2024 | June 30, 2025 | MCNAMARA, PATRICK J | reporter.nih.gov |
| Novel molecular therapies for CPVT | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $340,330 | July 12, 2018 | June 30, 2023 | BEZZERIDES, VASSILIOS JAMES | reporter.nih.gov |
| Biogenesis of hERG1a/1b ion channels in health and disease model cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $339,294 | July 5, 2024 | June 30, 2025 | FLORES ALDAMA, LISANDRA | reporter.nih.gov |
| The Role of End-Binding Protein 2 and Microtubule Network in Inherited Cardiac Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $336,416 | August 1, 2022 | January 31, 2025 | CHIANG, DAVID YI-ENG | reporter.nih.gov |
| Statistical Methods for Analyzing Birth Defects Cohorts | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2022 | $335,000 | April 1, 2021 | March 31, 2025 | ZHAO, HONGYU | reporter.nih.gov |
| Mural cells contribution to vascular remodeling in flow induced pulmonary hypertension | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $332,843 | September 20, 2024 | August 31, 2029 | KLOUDA, TIMOTHY | reporter.nih.gov |
| Moonlighting in Mitochondria: A Non-Canonical Role for Cardiac Troponin I in Inherited Cardiomyopathies | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $331,344 | August 1, 2024 | July 31, 2029 | ELEZABY, ALY | reporter.nih.gov |
| The Association of Damaging Genetic Variation With Ventricular Function in Hypoplastic Left Heart Syndrome | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $323,936 | August 1, 2018 | July 31, 2024 | LEWIS, MATTHEW | reporter.nih.gov |
| Expandable Pediatric Pulmonary Heart Valve | NIH | National Heart, Lung, and Blood Institute | 2025 | $321,679 | September 1, 2025 | August 31, 2027 | SIERAD, LESLIE NEIL | reporter.nih.gov |
| A Fail Safe, High Output Failing Fontan Pump | NIH | National Heart, Lung, and Blood Institute | 2025 | $320,838 | September 5, 2025 | February 28, 2027 | SMITH, WILLIAM A | reporter.nih.gov |
| Computational analysis of whole genome sequence data for discovering novel risk genes of structural birth defects | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $319,230 | August 1, 2022 | July 31, 2025 | SHEN, YUFENG | reporter.nih.gov |
| Genetic Contributions to Valvar Pulmonary Stenosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $318,000 | July 19, 2022 | June 30, 2024 | WEAVER, KATHRYN NICOLE | reporter.nih.gov |
| Uncovering incomplete penetrance genes in congenital heart disease by integrative analysis of Common Fund data | NIH | Office of the Director, National Institutes of Health | 2025 | $316,000 | June 10, 2025 | May 31, 2027 | KOBOLDT, DANIEL | reporter.nih.gov |
| Enriching medical phenotypes and environmental traits in the large DS360 Down syndrome cohort | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 | $313,000 | May 1, 2022 | April 30, 2025 | ROSSER, TRACIE C | reporter.nih.gov |
| Curation and analysis of publicly available, molecular profiles from people with Down Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $310,521 | June 1, 2024 | May 31, 2027 | PICCOLO, STEPHEN | reporter.nih.gov |
| Mechanisms for cell signaling in the control of cardiomyogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 | $309,589 | August 1, 2016 | August 15, 2023 | SONG, KUNHUA | reporter.nih.gov |
| Biomimetic size-adaptable heart valve for prosthesis-patient mismatch | NIH | National Heart, Lung, and Blood Institute | 2021 | $299,994 | January 1, 2021 | December 31, 2021 | DEL NIDO, PEDRO J. | reporter.nih.gov |
| 1/2 Milrinone for Prevention of Post-Patent Ductus Arteriosus Closure Syndrome in Extremely Preterm Infants (MIDAS Trial) – CCC | NIH | National Heart, Lung, and Blood Institute | 2025 | $296,469 | July 1, 2024 | June 30, 2029 | MCNAMARA, PATRICK J | reporter.nih.gov |
| Multi-scale computational modeling of calmodulin mutations associated with CPVT | NIH | National Institute of General Medical Sciences | 2024 to 2025 | $295,000 | May 1, 2024 | April 30, 2028 | SHIFERAW, YOHANNES | reporter.nih.gov |
| Sphingosine kinase 1 plays a key role in defective elastin-induced arterial hypermuscularization | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $279,158 | April 1, 2024 | August 31, 2025 | SAITO, JUNICHI | reporter.nih.gov |
| Gene Expression Networks for Human Cardiac Differentiation in Down Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $277,548 | September 1, 2020 | August 31, 2023 | MOSKOWITZ, IVAN PAUL | reporter.nih.gov |
| Newborn Screening for Critical Congenital Heart Disease in U.S.: Assessment of implementation obstacles and application of cost-effectiveness to gauge if action needed for improved implementation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $275,156 | June 1, 2018 | May 31, 2024 | SAKAI-BIZMARK, RIE | reporter.nih.gov |
| Determination of Persistent Inflammation, Immunosuppression, and Catabolism Syndrome in the Pediatric Cardiac ICU | NIH | National Heart, Lung, and Blood Institute | 2025 | $271,938 | August 15, 2025 | July 31, 2027 | STARK, RYAN J | reporter.nih.gov |
| Multimodal Characterization of Cardiac-Neurodevelopmental Genes | NIH | National Heart, Lung, and Blood Institute | 2025 | $267,000 | August 1, 2025 | July 31, 2027 | MORTON, SARAH UHLER | reporter.nih.gov |
| Impact of phthalate and phenol exposures on congenital heart surgery outcomes | NIH | National Institute of Environmental Health Sciences | 2022 | $259,073 | May 18, 2022 | April 30, 2023 | KUIPER, JORDAN RICHARD | reporter.nih.gov |
| Deciphering the intrinsic myocardial and/or endocardial defects of hypoplastic left heart syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $254,556 | March 1, 2024 | February 28, 2027 | HUANG, MENGMENG | reporter.nih.gov |
| Critical roles of CHD7 during mouse cardiogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 | $253,153 | January 1, 2010 | March 31, 2022 | JIAO, KAI | reporter.nih.gov |
| Systems biology of acute and chronic multi-organ failure in children with congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $252,118 | September 1, 2024 | August 31, 2029 | DAVIDSON, JESSE | reporter.nih.gov |
| Cellular and Molecular Mechanisms of Atrial Cardiomyocyte Lineage Commitment | NIH | National Heart, Lung, and Blood Institute | 2021 | $249,998 | April 15, 2019 | March 31, 2022 | LI, GUANG | reporter.nih.gov |
| Electrical excitability in vascular smooth muscle: from rare disease to new paradigms | NIH | National Heart, Lung, and Blood Institute | 2022 | $249,000 | June 1, 2022 | May 31, 2023 | MCCLENAGHAN, CONOR | reporter.nih.gov |
| Sphingosine kinase 1 plays a key role in defective elastin-induced arterial hypermuscularization | NIH | National Heart, Lung, and Blood Institute | 2025 | $249,000 | September 1, 2025 | August 31, 2028 | SAITO, JUNICHI | reporter.nih.gov |
| The Role of End-Binding Protein 2 and Microtubule Network in Inherited Cardiac Arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2025 | $248,363 | April 18, 2025 | March 31, 2028 | CHIANG, DAVID YI-ENG | reporter.nih.gov |
| SCN5A (Nav1.5): Predicting the Consequence of Missense Single- Nucleotide Polymorphisms. | NIH | National Heart, Lung, and Blood Institute | 2021 | $246,330 | February 5, 2019 | January 31, 2022 | KRONCKE, BRETT M | reporter.nih.gov |
| Intrauterine Programming of Diabetes Induced Cardiac Embyropathy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $246,240 | January 1, 2018 | December 31, 2023 | LISTER, ROLANDA LAMORA | reporter.nih.gov |
| Novel Therapeutics for Long QT Syndrome | NIH | National Heart, Lung, and Blood Institute | 2022 | $245,540 | September 22, 2022 | June 30, 2023 | YAZAWA, MASAYUKI | reporter.nih.gov |
| Mentoring in Pediatric Cardiovascular Pharmacology and Early Phase Trials | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $242,118 | March 1, 2024 | February 28, 2029 | HORNIK, CHRISTOPH | reporter.nih.gov |
| Cyclic stretch of bicuspid aortic valves: elucidating its implications for cell signaling and tissue mechanics. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $239,068 | April 1, 2023 | March 31, 2026 | WEST, TONI MCCLISH | reporter.nih.gov |
| Machine Learning Based Analysis of Longitudinal Changes in the Congenital Heart Disease Electrocardiogram | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $234,750 | August 1, 2024 | July 31, 2027 | BOOK, WENDY M. | reporter.nih.gov |
| Secondary Analysis of Noninvasive Imaging Biomarkers for the Early Prediction of Single Ventricle Failure | NIH | National Heart, Lung, and Blood Institute | 2025 | $234,000 | August 1, 2025 | July 31, 2027 | HUNTER, KENDALL STEPHEN | reporter.nih.gov |
| Natural language processing and machine learning for development of a Fontan Failure risk prediction model from electronic health records | NIH | National Heart, Lung, and Blood Institute | 2025 | $232,498 | August 15, 2025 | July 31, 2027 | BOOK, WENDY M. | reporter.nih.gov |
| A Multi-omic approach towards improving candidate gene identification and variant prioritization in patients with congenital heart disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $231,000 | January 1, 2022 | December 31, 2024 | GARG, VIDU | reporter.nih.gov |
| Functional assessment of atrial myosin mutations in familial atrial arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2025 | $231,000 | September 1, 2025 | August 31, 2027 | KAWANA, MASATAKA | reporter.nih.gov |
| Random Field Modelling of genetic and epigenetic association underlying congenital heart defects in the presence of disease heterogeneity | NIH | National Heart, Lung, and Blood Institute | 2021 | $218,783 | January 1, 2021 | January 9, 2023 | LI, MING | reporter.nih.gov |
| Mechanisms linking the frail sarcomere to noncompaction cardiomyopathy | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $217,870 | August 1, 2023 | July 31, 2025 | MONROE, TANNER O | reporter.nih.gov |
| Primary cilia as regulators of vascular stability during embryonic development | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $216,810 | July 1, 2024 | June 30, 2027 | WILSON-COLIJN, SARAH ANN | reporter.nih.gov |
| Impact of phthalate and phenol exposures on congenital heart surgery outcomes. | NIH | National Institute of Environmental Health Sciences | 2023 | $213,595 | May 18, 2022 | April 30, 2025 | KUIPER, JORDAN RICHARD | reporter.nih.gov |
| Acute Prenatal Alcohol Exposure Potentiates Conotruncal Defects in the Setting of a Permissive Genetic Background | NIH | National Institute on Alcohol Abuse and Alcoholism | 2022 to 2025 | $212,959 | May 18, 2022 | May 17, 2027 | HARVEY, DRAYTON C | reporter.nih.gov |
| A Platform for Outcomes Data Sharing and Pre-Operative Image-Guided Mechanistic Assessment for Bicuspid Aortic Valve Repair Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $211,356 | September 1, 2018 | May 31, 2023 | POUCH, ALISON MARIE | reporter.nih.gov |
| Regulation of Fibronectin expression in the neural crest during vascular morphogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $206,854 | April 1, 2020 | March 31, 2023 | ALEXANDER, BRIANNA | reporter.nih.gov |
| Right Ventricular Remodeling in Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $206,439 | August 1, 2022 | July 31, 2027 | THOMPSON, ELIZABETH WALKER | reporter.nih.gov |
| Heart Failure in Single Right Ventricle Physiology: Pathologic Mechanisms and Novel Assessment | NIH | National Heart, Lung, and Blood Institute | 2021 | $200,772 | August 1, 2017 | June 30, 2023 | CHOWDHURY, SHAHRYAR M. | reporter.nih.gov |
| Probing mechanisms of long QT type 2-associated neuronal dysfunction using gene-edited stem cell-derived neurons | NIH | National Institute of Neurological Disorders and Stroke | 2025 | $195,000 | December 1, 2024 | November 30, 2026 | JONES, DAVID K. | reporter.nih.gov |
| Evaluation of First-Degree Relatives after Sudden Unexplained Death | NIH | National Heart, Lung, and Blood Institute | 2021 | $190,008 | August 1, 2017 | June 30, 2022 | WEBSTER, ROBERT GREGORY | reporter.nih.gov |
| Fetal markers of neurodevelopmental outcomes in congenital heart disease | NIH | National Institute of Neurological Disorders and Stroke | 2021 | $188,245 | June 1, 2017 | May 31, 2022 | PEYVANDI, SHABNAM | reporter.nih.gov |
| Uncovering the Mechanism of Potassium Channel Folding and Assembly with Implications for the Molecular Basis of Cardiac Arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $185,889 | January 1, 2022 | June 30, 2025 | MOLINA, ANDREW VINCENT | reporter.nih.gov |
| Immune system evasion of stem cell-derived cardiomyocytes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $183,957 | July 14, 2020 | July 18, 2022 | GARBERN, JESSICA | reporter.nih.gov |
| Defining the molecular regulators of valvular delamination via multi-omic dissection of Ebstein’s Anomaly | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $183,044 | April 1, 2021 | March 31, 2025 | MERRIMAN, ALEXANDER FLAHERTY | reporter.nih.gov |
| Ventricular and Pulmonary Vascular Reserve after the Fontan Operation | NIH | National Heart, Lung, and Blood Institute | 2021 | $173,275 | April 1, 2018 | July 31, 2021 | EGBE, ALEXANDER | reporter.nih.gov |
| Developing near-infrared responsive liquid crystal elastomers for an adjustable pulmonary artery band | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $172,354 | August 17, 2022 | August 16, 2026 | SKILLIN, NATHANIEL PHILLIP | reporter.nih.gov |
| Genome Editing Treatment for Catecholaminergic Polymorphic Ventricular Tachycardia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $172,170 | March 1, 2021 | September 30, 2024 | MOORE, OLIVER | reporter.nih.gov |
| Novel Cardiac MRI-Based Predictors for Tetralogy of Fallot: Deformation, Kinematic, and Geometric Analyses | NIH | National Heart, Lung, and Blood Institute | 2021 | $169,351 | February 15, 2021 | September 1, 2021 | TANDON, ANIMESH | reporter.nih.gov |
| Prenatal Care and Postnatal Outcomes for Publicly Insured Children with Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2025 | $168,480 | April 10, 2025 | March 31, 2030 | WOO, JOYCE L | reporter.nih.gov |
| Precision Prediction of Right Ventricular Size, Function, and Outcomes in Patients with Repaired Tetralogy of Fallot | NIH | National Heart, Lung, and Blood Institute | 2025 | $167,588 | March 1, 2025 | February 28, 2030 | DUONG, SON QUANG | reporter.nih.gov |
| Functional Characterization of Phosphodiesterase 1 in Single Ventricle Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2021 | $165,240 | January 1, 2017 | December 31, 2022 | NAKANO, STEPHANIE JIALING | reporter.nih.gov |
| A genetic and molecular approach to understanding allelic and phenotypic heterogeneity in Acrofacial dysostosis, Cincinnati-type | NIH | National Heart, Lung, and Blood Institute | 2021 | $162,980 | April 11, 2019 | March 31, 2023 | WEAVER, KATHRYN NICOLE | reporter.nih.gov |
| Identifying Angiocrine Factors for Cardiomyocyte Maturation Using Single-Cell Sequencing | NIH | National Heart, Lung, and Blood Institute | 2021 | $162,432 | February 1, 2020 | January 31, 2023 | PAIK, DAVID T | reporter.nih.gov |
| Establishing Basic Science-Clinical Collaborations to Understand the Molecular Mechanisms of Heterotaxy | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $161,500 | August 1, 2024 | July 31, 2026 | KULKARNI, SAURABH S | reporter.nih.gov |
| Defining new pathways for complex human heart failure and arrhythmia | NIH | National Heart, Lung, and Blood Institute | 2021 | $160,920 | April 20, 2020 | July 31, 2021 | BRADLEY, ELISA ANN | reporter.nih.gov |
| The Role of RERE and SPEN in the development of 1p36 Deletion-Related Congenital Heart Defects | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2024 | $160,000 | July 22, 2024 | June 30, 2026 | SCOTT, DARYL ARMSTRONG | reporter.nih.gov |
| Revealing the mechanisms of neural-mediated cardiac proliferation in Ciona robusta | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $159,984 | September 1, 2023 | August 31, 2026 | GRUNER, HANNAH | reporter.nih.gov |
| A Dynamic and Three-Dimensional Human Model of Hypoplastic Left Heart Syndrome to Probe Compromised Cardiomyocyte Proliferation | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $156,980 | September 16, 2024 | September 15, 2027 | ALONZO, MATTHEW | reporter.nih.gov |
| Dissecting the spectrum of genetic architectures underlying congenital heart defects. | NIH | National Heart, Lung, and Blood Institute | 2021 | $156,000 | January 1, 2020 | December 31, 2022 | ARBOLEDA, VALERIE A | reporter.nih.gov |
| Maternal dietary intake of omega 3 fatty acids and birth defects | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2023 to 2024 | $156,000 | May 18, 2023 | July 31, 2025 | WALLER, DOROTHY KIM | reporter.nih.gov |
| Assessing myofilament phenotype and contractile response to pharmacotherapies in a human induced pluripotent stem cell cardiomyocyte (hiPSC-CM) model of hypoplastic left heart syndrome (HLHS) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $155,500 | August 3, 2021 | July 31, 2023 | NAKANO, STEPHANIE JIALING | reporter.nih.gov |
| Targeting pathologic intracellular calcium release to prevent lethal arrhythmias | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $149,235 | June 1, 2023 | May 31, 2026 | GOCHMAN, AARON | reporter.nih.gov |
| 3D Bioprinted Collagen Vascular Conduits For Use In Patients With Congenital Heart Defects | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $145,616 | September 1, 2022 | June 30, 2024 | ASHRAF, SYED FAAZ | reporter.nih.gov |
| Biomechanical Optimization of Mitral Valve Repair Operations and Annuloplasty Rings for Primary Mitral Valve Regurgitation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $144,400 | July 1, 2021 | June 30, 2023 | ZHU, YUANJIA | reporter.nih.gov |
| Dynamic Modeling of Mechanotransduction in the Bicuspid Aortic Valve: Separating the Effects of Altered VICs and Mechanics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $144,400 | September 1, 2020 | August 31, 2023 | HOWSMON, DANIEL PAUL | reporter.nih.gov |
| Defining the downstream genetic networks regulated by GATA6 during human cardiogenesis using iPSC and hESC models | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $144,400 | June 1, 2020 | May 31, 2023 | BISSON, JOSEPH A | reporter.nih.gov |
| Circadian Regulation of Cardiomyocyte Size and Function | NIH | National Heart, Lung, and Blood Institute | 2025 | $143,829 | January 1, 2025 | December 31, 2029 | BLAIR, CHEAVAR | reporter.nih.gov |
| Quantitative Magnetic Resonance Properties of Cerebrospinal Fluid and Brain Health Outcomes in Pediatric Congenital Heart Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $143,420 | September 1, 2022 | August 31, 2025 | LEE, VINCENT KYU | reporter.nih.gov |
| Dual-Venc 5D flow for Assessment of Congenital Heart Disease in Pediatrics | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $142,680 | July 1, 2023 | August 31, 2026 | WEISS, ELIZABETH | reporter.nih.gov |
| Cardiac 1H MRS assessment of NAD+ after Tetralogy of Fallot repair | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $140,482 | September 1, 2021 | August 31, 2024 | SWAGO, SOPHIA | reporter.nih.gov |
| Regulation of cardiac chamber morphology in zebrafish | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $140,296 | August 1, 2020 | July 31, 2023 | LEERBERG, DENA MARIE | reporter.nih.gov |
| Genetic dissection of fluid flow signaling in Left-Right patterning of zebrafish | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2022 to 2024 | $140,191 | July 1, 2022 | June 30, 2025 | FISHER, KATHERINE H | reporter.nih.gov |
| Targeting Mek/Erk Signaling in the Treatment of Mitral Valve Prolapse | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $139,580 | July 1, 2021 | June 30, 2024 | BECK, TYLER | reporter.nih.gov |
| Brain Abnormalities and Neurobehavioral Deficits in Hypoplastic Left Heart Syndrome | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $136,994 | May 17, 2019 | October 16, 2023 | GABRIEL, GEORGE CHRISTOPHER | reporter.nih.gov |
| Defining the Cellular Morphogenic Behaviors that Shape the Developing Heart | NIH | National Heart, Lung, and Blood Institute | 2022 to 2023 | $136,674 | January 1, 2022 | December 31, 2023 | MUNCIE-VASIC, JONATHON MICHAEL | reporter.nih.gov |
| Functional and molecular mechanisms of human calmodulinopathy in cardiac arrhythmias and sudden cardiac death | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $136,192 | September 30, 2020 | September 29, 2023 | WOLTZ, RYAN LEE | reporter.nih.gov |
| Uncovering the Mechanisms that Enable Cardiac Progenitors to Build the Linear Heart Tube | NIH | National Heart, Lung, and Blood Institute | 2025 | $134,998 | July 20, 2025 | May 31, 2027 | MUNCIE-VASIC, JONATHON MICHAEL | reporter.nih.gov |
| Embryologic Origins of Aortopathy: Biomechanical Characterization of Aortic Aneurysms in the NOTCH1 Mutant Model | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $133,801 | September 1, 2021 | June 30, 2023 | ACKAH, RUTH | reporter.nih.gov |
| Use of Predictive Analytics to Quantify Neonatal Hypothermia Burden After Cardiac Surgery | NIH | National Institute of Nursing Research | 2021 to 2023 | $133,652 | July 1, 2021 | December 31, 2023 | HELMAN, STEPHANIE M | reporter.nih.gov |
| Improving mutant KV11.1 trafficking to treat Long QT Syndrome | NIH | National Heart, Lung, and Blood Institute | 2025 | $131,571 | September 1, 2025 | August 31, 2030 | EGLY, CHRISTIAN L | reporter.nih.gov |
| Ontogeny and Genetics of NSAID Dose-Exposure Relationship in Preterm Infants | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 | $129,022 | September 25, 2018 | December 31, 2021 | LEWIS, TAMORAH R | reporter.nih.gov |
| 4D Virtual Catheter (vCath) Assessment of Hemodynamic Pathways in Aortopathy Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 | $119,125 | February 1, 2020 | January 31, 2024 | ELBAZ, MOHAMMED | reporter.nih.gov |
| Retinoic acid-dependent mechanisms patterning the cardiac progenitor fields | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $111,191 | March 1, 2021 | December 8, 2023 | DUONG, TIFFANY | reporter.nih.gov |
| Investigation of Chromatin Modifiers to Elucidate the Phenotypic Variability of Congenital Heart Disease in Patients with 22q11.2 Deletion Syndrome | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $108,512 | January 16, 2024 | July 15, 2027 | MILLER, DANIELLA | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 15 | $37.2 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 33 | $35.6 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 22 | $28.6 million | 0 | $0 |
| University of Hawaii | Honolulu, HI | 1 | $25.5 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 14 | $22.5 million | 0 | $0 |
| Stanford University | Stanford, CA | 19 | $19.9 million | 0 | $0 |
| Yale University | New Haven, CT | 21 | $18.3 million | 0 | $0 |
| J. David Gladstone Institutes | San Francisco, CA | 9 | $17 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 10 | $16.3 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 12 | $16.2 million | 0 | $0 |
| Columbia University Health Sciences | New York, NY | 17 | $15.3 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 17 | $15.2 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 11 | $14.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 15 | $13.5 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 7 | $13.4 million | 0 | $0 |
| Children's Research Institute | Washington, DC | 10 | $12.9 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 12 | $12.3 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 6 | $12.2 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 5 | $12 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 7 | $11.1 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 11 | $10.4 million | 0 | $0 |
| Medical University of South Carolina | Charleston, SC | 9 | $10.2 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 4 | $9.5 million | 0 | $0 |
| Emory University | Atlanta, GA | 13 | $9.1 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 5 | $8.4 million | 0 | $0 |
| University of Washington | Seattle, WA | 5 | $7.4 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 9 | $7.1 million | 0 | $0 |
| Children's Hosp of Philadelphia | Philadelphia, PA | 6 | $7.1 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 5 | $7 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 3 | $6.9 million | 0 | $0 |
| Starlight Cardiovascular, Inc. | San Diego, CA | 5 | $6.7 million | 0 | $0 |
| Washington University | Saint Louis, MO | 9 | $6.2 million | 0 | $0 |
| Duke University | Durham, NC | 6 | $6.1 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 5 | $6 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 4 | $5.8 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 4 | $5.8 million | 0 | $0 |
| University of Chicago | Chicago, IL | 7 | $5.4 million | 0 | $0 |
| Vanderbilt University | Nashville, TN | 8 | $4.8 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 6 | $4.6 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 5 | $4.6 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 5 | $4.4 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 4 | $4.4 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 2 | $4.3 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 5 | $4.3 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 4 | $4.3 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 4 | $4.2 million | 0 | $0 |
| Ohio State University | Columbus, OH | 6 | $4.1 million | 0 | $0 |
| Annoviant, INC | Alpharetta, GA | 1 | $4 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 2 | $3.8 million | 0 | $0 |
| University of California at Davis | Davis, CA | 3 | $3.7 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 6 | $3.6 million | 0 | $0 |
| Texas A&m University Health Science CTR | College Station, TX | 2 | $3.6 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 4 | $3.5 million | 0 | $0 |
| University of Houston | Houston, TX | 2 | $3.4 million | 0 | $0 |
| Sanford Burnham Prebys Medical Discovery Institute | La Jolla, CA | 1 | $3.3 million | 0 | $0 |
| Rutgers Biomedical and Health Sciences | Newark, NJ | 5 | $3.3 million | 0 | $0 |
| Polyvascular INC | Houston, TX | 1 | $3.2 million | 0 | $0 |
| Children's Hospital of Los Angeles | Los Angeles, CA | 4 | $3.2 million | 0 | $0 |
| Cornell University | Ithaca, NY | 1 | $3.1 million | 0 | $0 |
| University of Calif-Lawrenc Berkeley Lab | Berkeley, CA | 1 | $3 million | 0 | $0 |
| Omniox, Inc. | San Francisco, CA | 1 | $3 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 1 | $3 million | 0 | $0 |
| New York University | New York, NY | 2 | $2.9 million | 0 | $0 |
| Harvard Medical School | Boston, MA | 2 | $2.9 million | 0 | $0 |
| Texas Heart Institute | Houston, TX | 2 | $2.8 million | 0 | $0 |
| Transmural Systems, LLC | Andover, MA | 1 | $2.5 million | 0 | $0 |
| University of South Carolina at Columbia | Columbia, SC | 2 | $2.4 million | 0 | $0 |
| Research Triangle Institute | Research Triangle Park, NC | 1 | $2.4 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 2 | $2.3 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 4 | $2.3 million | 0 | $0 |
| Narrows Institute for Biomedical Res INC | Brooklyn, NY | 1 | $2.3 million | 0 | $0 |
| George Washington University | Washington, DC | 2 | $2.3 million | 0 | $0 |
| Michigan State University | East Lansing, MI | 1 | $2.2 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 3 | $2.1 million | 0 | $0 |
| University of South Florida | Tampa, FL | 2 | $2.1 million | 0 | $0 |
| California Institute of Technology | Pasadena, CA | 2 | $1.9 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 1 | $1.9 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 1 | $1.9 million | 0 | $0 |
| Rensselaer Polytechnic Institute | Troy, NY | 1 | $1.8 million | 0 | $0 |
| Heartpoint Global INC | Coral Gables, FL | 1 | $1.8 million | 0 | $0 |
| Khloris Biosciences, Inc. | South San Francisco, CA | 1 | $1.7 million | 0 | $0 |
| Onocor, LLC | Philadelphia, PA | 1 | $1.7 million | 0 | $0 |
| Rhode Island Hospital | Providence, RI | 1 | $1.6 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 3 | $1.5 million | 0 | $0 |
| SUNY at Stony Brook | Stony Brook, NY | 1 | $1.5 million | 0 | $0 |
| Institute for Basic Res in Dev Disabil | Staten Island, NY | 1 | $1.4 million | 0 | $0 |
| Children's Mercy Hosp (kansas City, Mo) | Kansas City, MO | 3 | $1.4 million | 0 | $0 |
| University of TX MD Anderson Can CTR | Houston, TX | 1 | $1.4 million | 0 | $0 |
| Harvard University | Cambridge, MA | 1 | $1.4 million | 0 | $0 |
| Loyola University Chicago | Maywood, IL | 1 | $1.3 million | 0 | $0 |
| Rbhs-New Jersey Medical School | Newark, NJ | 5 | $1.3 million | 0 | $0 |
| Ihc Health Services, Inc. | Salt Lake City, UT | 1 | $1.2 million | 0 | $0 |
| University of Florida | Gainesville, FL | 4 | $1.2 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 1 | $1.2 million | 0 | $0 |
| University of Texas at Austin | Austin, TX | 4 | $1.1 million | 0 | $0 |
| Upstate Medical University | Syracuse, NY | 2 | $1.1 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 1 | $1 million | 0 | $0 |
| University of Rochester | Rochester, NY | 1 | $1 million | 0 | $0 |
| Elex Biotech, LLC | Portland, OR | 1 | $971,323 | 0 | $0 |
| Kennesaw State University | Kennesaw, GA | 2 | $948,267 | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 262 | $131,831,301 | 0 | $0 |
| 2024 | 282 | $145,214,717 | 0 | $0 |
| 2023 | 265 | $136,974,040 | 0 | $0 |
| 2022 | 275 | $135,451,703 | 0 | $0 |
| 2021 | 264 | $126,823,385 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.